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Cancer is currently the leading cause of death worldwide, causing over 8 million deaths 
in 2012 [1]. In the Netherlands, about 1 out of three women and 1 out of two men re-
ceive a diagnosis of cancer at some point in their life [2]. Due to improved detection, an 
ageing population and an increase in risk factors (e.g. tobacco use, unhealthy diet and 
physical inactivity) the incidence of cancer is expected to increase during the coming 
decades [1,2]. Luckily, survival increases as well because of improved cancer detection 
and treatment [2]. Many cancers are curable if detected early and treated adequately.
In the majority of the chapters within this thesis, the focus is on cancer patients 
in general, irrespective of cancer type and stage. In two chapters, studies are being 
described in which only patients with breast cancer participate. The patients who are 
enrolled in these studies are patients with breast cancer treated with curative intent.
Breast cancer is the most prevalent cancer in women worldwide [3]. The lifetime 
risk of being diagnosed with breast cancer in the Netherlands is about 1 in 7 (invasive 
cancer and pre-cancer stage (DCIS) [2,4]). The incidence is expected to increase during 
the coming years [5]. Next to better detection and an ageing population, risk factors for 
breast cancer such as having no/few children or having a first child after the age of 30, 
no or short breastfeeding, being overweight (after menopause), high alcohol consump-
tion and a lack of physical exercise changed in an unfavorable direction during the last 
years [5]. The survival rate of breast cancer is relatively high and is expected to further 
increase. In 2012, the five-year survival rate of breast cancer was 87% compared to 
62% across all primary cancer sites [2].
Psychosocial impact of cancer diagnosis and treatment
Receiving a diagnosis of cancer and undergoing (different types of) treatment (Box 1) 
poses major challenges to patients’ coping abilities. Coping has been defined as the 
way an individual deals with a stressor (e.g. cancer). Coping strategies can be active 
(trying to change the stressor itself) or passive (change how one relates to the stress-
or). According to the transactional model of stress and coping of Lazarus and Folkman 
(1984), coping depends on how one appraises a stressor. When encountering a stress-
or, an individual primarily appraises the stressor as either threatening or non-threaten-
ing, and secondarily in terms of whether one has the resources to cope with the stress-
or effectively (figure 1). Well-being deteriorates when an individual appraises that the 
demands of the stressor exceed personal resources [6].
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General introduction
Box 1. Cancer treatment – a quick glance
After being diagnosed with cancer, treatment will be administered with a curative 
(to cure the illness) or palliative intent (to relieve symptoms, to improve quality 
of life and/or to prolong life). Several treatment modalities can be used to treat 
cancer, depending on the type of cancer, the characteristics of the tumor, the 
preferences and fitness of the patient. The following treatment modalities can 
be administered either alone or in combination:
Surgery. Most patients with cancer will receive some type of surgery. Surgery can 
be used to diagnose, treat and/or to prevent cancer. If cancer has not spread to 
other parts of the body, surgery provides the best chance for cure. Concerning 
breast cancer, part of the breast that contains the malignancy (lumpectomy) or the 
whole breast (mastectomy) can be removed, often in combination with a lymph 
node examination. The type of surgery depends on tumor-related characteristics 
and the patient’s wishes. Patients can opt for a direct reconstruction of the breast 
(cosmetic surgery) or decide later on. Side effects that can occur, especially after a 
lymph node dissection are; pain/numbness, limitations in arm-shoulder function 
and lymphedema.
Radiotherapy. This therapy uses X-rays or other high-energy particles from 
linear accelerator machines to destroy or damage cancer cells. The total dose of 
radiotherapy is usually divided into smaller doses (fractions). Patients with breast 
cancer may receive up to 22 fractions. The side effects most commonly reported 
are a loss of energy and skin complaints in the treated area.
Proton therapy is a newer type of radiotherapy that uses protons rather than 
X-rays to treat cancer. With proton therapy, there is less radiation dose outside 
of the tumor, possibly resulting in fewer side effects than standard radiotherapy. 
For breast cancer, proton therapy is only applied when fewer side effects are 
expected compared to standard radiotherapy.
 
Systemic therapy. In contrast to surgery and radiotherapy that treat cancer locally, 
systemic therapy works throughout the whole body.
1
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Chapter 1
• Chemotherapy: this therapy uses a medicine or drug (cytotoxic drugs) to kill 
cancer cells. Chemotherapy is usually being administered by an injection or 
by intravenous infusion and is given in cycles, with rest periods in between. 
The frequency and length of chemotherapy varies, depending on (among 
others): the type of cancer, the types of drugs administered, and the 
expected toxicities of the drugs. Breast cancer patients may receive up to 
16 cycles of chemotherapy. Side effects are common with chemotherapy. 
Most frequent side effects are fatigue, hair loss, nausea, vomiting and bone 
marrow depression.
• Targeted therapy: this therapy is a type of cancer treatment that uses drugs 
or other substances to more precisely identify and attack cancer cells. 
Targeted therapy works by targeting the cancer’s specific genes, proteins, 
or the tissue environment that contributes to cancer growth and survival. 
These genes and proteins are found in cancer cells or in cells related to 
cancer growth, like blood vessel cells. Examples are monoclonal antibodies 
such as trastuzumab and pertuzumab administered in breast cancer 
patients. A substantial part of targeted therapy used in clinical practice 
is hormonal therapy.
• Hormonal therapy: this therapy uses a medicine to block the effects of 
hormones as some cancers use hormones to grow. Hormonal therapy is 
frequently used as part of breast cancer treatment, especially when the 
tumor is sensitive to the female hormones estrogen and/or progesterone 
and has unfavorable prognostic characteristics. Hormonal therapy is 
generally given for five years to breast cancer patients who receive curative 
treatment. The drug is most often taken as a pill on a daily basis (tamoxifen, 
aromatase inhibitors). The most common side effects are: hot flushes, 
vaginal dryness, painful joints, mood changes and weight changes.
• Immunotherapy: Immunotherapy is a cancer treatment that uses 
substances made by the body or in a laboratory to improve or restore 
the immune system function. There are several types of immunotherapy 
including the administration of cytokines or immune checkpoint inhibitors.
After cancer treatment ends, patients will continue to visit the hospitals for 
routine follow-up visits. During the follow-up visits, patients will be examined on 
cancer recurrence and presence of other malignancies. Treatment side-effects 
and general well-being are also discussed with the patient.
538881-L-sub01-bw-Admiraal
Processed on: 13-12-2019 PDF page: 13
13
General introduction









Figure 1. Stress-coping model of Lazarus & Folkman (1984)
 
The outcome of the appraisal process may elicit a range of emotional reactions in pa-
tients. A significant proportion of patients with cancer develop a psychiatric/psycholog-
ical mood disorder such as depression, anxiety and adjustment disorder at some point 
in the cancer trajectory. About 30-40% of patients in hospital settings experience one 
or a combination of these mood disorders [7-10]. Many emotional reactions to a can-
cer diagnosis and its treatment cannot be captured by any formal psychiatric/psycho-
logical diagnosis however [11]. Therefore, the concept of ‘distress’ has been introduced 
[12]. Distress has been defined as:
“a multifactorial unpleasant emotional experience of a psychological (cognitive, 
behavioral, emotional), social, and/or spiritual nature that may interfere with the ability 
to cope with cancer, its physical symptoms and its treatment. Distress extends along a 
continuum, ranging from common normal feelings of vulnerability, sadness, and fears, to 
problems that can become disabling such as depression, anxiety, panic, social isolation 
and spiritual crisis” [13]
The advantages of the concept of distress is the avoidance of the stigma often tied to 
psychiatric/psychological diagnoses and the usefulness for both mental and non-men-
tal health care professionals. Moreover, the concept is easy to understand and to re-
port by patients [12,14]. Distress has been associated with reduced health-related 
quality of life [15,16], low satisfaction with medical care [17] and decreased treatment 
adherence [18]. About 80% of patients experience elevated distress about one months 
after completion of primary treatment [19]. Fortunately, distress is transient for the 
majority of patients with cancer (±67%), for whom distress levels remain low or which 
decline swiftly after treatment completion [20-22]. Fifteen to 21% report stable high 
levels of distress up to 15 months post-diagnosis which may not remit spontaneously 
1
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Chapter 1
[20,21,23]. Additional support and/or a referral to health care services may alleviate 
the problems distressed patients suffer from.
Screening for distress and referral wish in clinical practice
Since the last quarter of the past century, attention to psychosocial problems of pa-
tients with cancer in clinical practice gradually increased and the subspecialty of psy-
cho-oncology emerged [24]. Distress has been recognized as the ‘6th vital sign’ after 
blood pressure, temperature, respiration, pulse, and pain [12]. Clinical practice guide-
lines on routine screening for distress have been developed in several countries such 
as the United States [13], United Kingdom [25], Canada [26], Australia [27] and the 
Netherlands [28]. These guidelines are an important step towards improving access to 
psychosocial and supportive health care.
The first version of the Dutch guideline ‘Screening for psychosocial distress’ (in 
Dutch: ‘Detecteren behoefte psychsociale zorg’) was published in 2010 and a revised 
version came out in 2017 [28]. The Dutch guideline describes several steps in the dis-
tress management process: 1) Distress screening by completion of a distress screening 
questionnaire; 2) discussion of patients’ response patterns on the distress screening 
questionnaire, and; 3) referral to appropriate services, if needed or wished, for treat-
ment of identified problems [28].
The Distress Thermometer (DT) showed to be a helpful tool in distress screening 
of patients with cancer [13,29-31]. This tool combined with the Problem List (PL), is 
central in the distress management guideline of the United States [13], Canada [26] 
and its validated Dutch version in the Dutch guideline [28]. The Dutch DT/PL (in Dutch: 
‘Lastmeter’; see appendix A for the Dutch and English versions of the DT/PL) assesses 
distress (scale ranging from 0-10), underlying problems covering the practical, social, 
emotional, spiritual and physical domains and includes a question concerning patients’ 
referral wish to a psychosocial or supportive health care professional [32]. Based on the 
international literature [30], the Dutch guideline (version 2017), perceives a patient as 
clinically distressed if patients report a DT score of 4 or higher (DT cutoff score; [28]). 
During the last few years, routine screening with the Dutch DT/PL has been implement-
ed in many oncology clinics in the Netherlands.
Guidelines for distress screening are widely disseminated but debate exists about 
whether distress screening should be implemented in clinical practise as the evidence 
on the effectiveness of distress screening seems inconsistent. However, recent reviews 
of the literature showed that distress screening has modest but significant benefits, es-
pecially on secondary outcomes such as communication with health care professionals 
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and referral to additional supportive health care services [28,33]. Noteworthy, distress 
screening is a vital component of the distress management process but is not valuable 
in itself [28]. Without appropriate management of distress and underlying problems, 
systematic adoption of distress screening in clinical practice is probably not worthwhile 
[33]. Thus, screening should be followed by an intervention and/or referral of (dis-
tressed) patients to enhance its effectiveness.
Although the DT/PL has been recommended as the preferred tool for screening 
and monitoring distress [34], knowledge about associates of high distress, underly-
ing problems and referral wish as measured by the DT/PL is limited. Instruments for 
distress screening in psycho-oncology often measure different areas of distress and 
thus, findings from studies concerning other distress screening questionnaires cannot 
be compared [35]. First, DT/PL validation studies mainly used mixed samples of pa-
tients with cancer. However, patients with cancer should not be perceived as a homo-
geneous group [36,37]: distress levels, DT cutoff scores and underlying problems may 
vary across different cancer subpopulations. For example, it is unclear whether distress 
levels, DT cutoff scores, underlying problems (PL) vary by cancer type [30]. Identical 
responses on the DT/PL across cancer types may not reflect the same in terms of clin-
ically elevated scores. This information is valuable in the discussion of patients’ re-
sponse patterns on the DT/PL and may guide subsequent actions to be taken by health 
care professionals. Additionally, knowledge about factors related to high distress may 
further assist in the identification of patients at risk of developing clinically elevated 
distress and can further guide clinical decision making of whom to refer to additional 
supportive health care services.
Second, few studies examined DT/PL responses in cancer survivors who are beyond 
the first year after completion of primary treatment i.e. longer-term cancer patients/
survivors [38]. As longer-term patients with cancer may experience lower emotional 
functioning and may suffer from lingering problems, even years after diagnosis [39,40], 
these studies may provide important knowledge about the severity of distress, nature 
of problems, and referral wish in this population. Several studies examined the course 
of distress over time in breast cancer survivors who were within the first 15 months 
after diagnosis [23,41]. A study using the DT/PL showed that one in five patients with 
breast cancer reported clinically elevated distress at both 6 and 15 months postdi-
agnosis [23]. However, no studies are known assessing DT/PL responses over time in 
longer-term (breast) cancer survivors. These studies may give important insight into 
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Third, the literature on factors associated with patients’ referral wish to psychosocial and 
supportive health care services is sparse and results are mostly contradictory. Knowledge 
of predictors may aid in the identification of patients who are in need of a referral [42]. 
This is especially important since distress and referral wish, though positively related, are 
not completely congruent. Not all distressed patients express a referral wish and some 
patients with low distress desire a referral (e.g. [32]).
In sum, better insight into the prevalence and factors associated with experiencing 
(continuing) high distress, underlying problems and into the factors related to having a 
referral wish as measured with the DT/PL can aid in timely identification and adequate 
management of patients’ distress and problems.
Web-based interventions to support patients with cancer
Timely management of prevailing problems is important to appropriately assist patients 
with cancer in adjusting to the cancer experience. Many patients wish for information 
about symptoms/problems that may arise after treatment completion and about strat-
egies how to cope with these problems [43,44]. The internet has been recognized as 
a viable medium by which patients can be educated and supported regarding distress 
caused by psychosocial and physical problems [45]. Web-based support programs can 
be of important value in management of these symptoms for several reasons. First, con-
sidering the growing number of patients with cancer, the health care system is urged 
to develop cost-effective interventions that are less resource intensive. Second, a shift 
from more traditional physician/caregiver care models towards patient centered-care 
models is emerging and calls for a higher involvement and increased self-management 
by patients. Educating patients regarding self-management of existing symptoms usually 
occurs during short encounters at the oncology clinic. However, patients need informa-
tion and support throughout the entire illness trajectory [46,47]. Web-based support 
programs can satisfy these needs. Other advantages of web-based support programs are 
its wide availability, accessibility, and ability to provide patient-tailored information and 
support [48-53].
Although new web-based support programs emerge at a rapid pace [54], relatively 
little is known about their effects on cancer patient reported outcomes. In patients with 
chronic diseases, these programs have been linked to positive outcomes such as increas-
es in knowledge, perceived social support, and in empowerment and improved health 
behaviors [55,56]. The available review studies in patients with cancer demonstrated 
promising but mixed efficacy [57,58]. The included studies in these reviews were often of 
poor quality in terms of study design and/or content of the web-based support programs 
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Psychosocial distress is common among cancer patients, especially during the first 
year after primary treatment completion (i.e. re-entry phase [59]) as patients may strug-
gle with psychosocial as well as physical difficulties. Tailored information and support are 
of marked importance during this phase to prevent and/or treat lingering problems. To 
date, only few rigorously tested web-based interventions for patients with cancer in the 
re-entry phase are available [60,61].
In sum, web-based programs which educate and support patients with cancer seem 
to have great potential but more evidence is needed to establish the value of these pro-
grams in supporting patients with cancer.
Study aims
As patients with cancer frequently experience distress from psychosocial and physical 
symptoms, adequate detection of these symptoms and referral wishes are essential to 
ensure that patients receive the psychosocial and/or supportive health care they need 
[62,63]. Detection requires appropriate identification of patients in need. The first part of 
this thesis aims to increase insight into the prevalence and associates of (continuing) high 
distress, underlying problems and referral wish as measured by the Dutch DT/PL.
Chapter 2 examines differences in DT cutoff scores, distress levels, and underlying 
problems between patients with different cancer types and stages. DT cutoff scores are 
helpful in deciding which patients may suffer from clinically elevated distress. The effect 
of socio-demographic and illness-related variables on distress are also examined. Knowl-
edge of the relationship between these variables and the level of distress may further aid 
in the identification of patients at risk for clinically elevated distress. A large heterogene-
ous sample of patients with cancer is included (N=1340) varying in socio-demographic 
and illness-related characteristics including cancer type and stages and varying in distress 
levels. Chapter 3 uses the same large sample and focuses on patients’ referral wish. The 
main study objective is to examine the effects of patients’ perceived distress and under-
lying problems, socio-demographic and illness-related variables, and social support suffi-
ciency on referral wish. We are especially interested in the variables that uniquely affect 
referral wish. Chapter 4 focuses specifically on DT/PL responses of longer-term survivors 
of breast cancer i.e. survivors who finished treatment with adjuvant chemotherapy 1-5 
years earlier. The study aims to contribute to our understanding of (clinically elevated) 
distress levels, problems, referral wish and health care use in this population over a one-
year time period. Also, variables associated with continuing elevated distress (i.e. a DT 
score of ≥5 at both measurements points) are explored.
1
538881-L-sub01-bw-Admiraal
Processed on: 13-12-2019 PDF page: 18
18
Chapter 1
The second part of this thesis examines the effects of web-based support programs on 
patient reported outcomes. As the available literature on the effect of these programs 
is limited, more information is needed to decide whether these programs can be used 
to support patients in clinical practice.
Chapter 5 reviews the current literature on the effects of web-based support pro-
grams on psychosocial and physical symptoms of patients with cancer. Only studies 
that were (randomized) controlled trials including a comparison group and web-based 
programs that were developed or moderated by (a) health care professional(s) are in-
cluded. The methodological quality of the included studies is evaluated and discussed. 
Chapter 6 describes a multicenter randomized controlled trial which examines the 
effects of a web-based tailored psycho-educational program for patients with breast 
cancer in the re-entry phase (ENCOURAGE program). The program aims to empower 
patients to take control over prevailing problems and to adjust to life after treatment. A 
problem-solving orientation is adopted in the development of the psycho-educational 
material as well as use of approach-oriented coping strategies. Several self-reported 
outcomes are assessed including patients’ optimism and feelings of control over the 
future. Finally, Chapter 7 provides an overall discussion of the findings as presented in 
the preceding chapters as well as suggestions for clinical practice and future research. 
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Objective: We examined differences in distress levels and Distress Thermometer (DT) 
cutoff scores between different cancer types. The effect of socio-demographic and 
illness-related variables on distress was also examined.
Methods: 1350 patients (response=51%) completed questions on socio-demographic 
and illness-related variables, the Dutch version of the DT and Problem List, and the 
Hospital Anxiety and Depression Scale. Receiver operating characteristics analyses 
were performed to determine cancer specific cutoff scores. Univariate and multivar-
iate effects of socio-demographic and illness-related variables (including cancer type) 
on distress were examined.
Results: Prostate cancer patients reported significantly lower DT scores (M=2.5+2.5) 
and the cutoff score was lower (≥4) than in patients with most other cancer types (M 
varied between 3.5-5.0; cutoff=≥5). Multivariate analyses (F=10.86, p<.001, R2=0.08) 
showed an independent significant effect of four variables on distress: intensive treat-
ment (β=0.10, any (combination of) treatment but surgery only and ‘wait and see’ 
(W&S)); a non-prostate cancer type (β=-0.17); the interaction between gender and age 
(β=-0.12, highest distress in younger women as compared to older women and young-
er and older men); and the interaction between cancer type and treatment intensity 
(β=0.08, lowest scores in prostate cancer patients receiving non-intensive treatment as 
compared to their counterparts).
Conclusions: Distress and cutoff score in prostate cancer patients were lower than in 
patients with other cancer types. Additionally, younger women and patients receiving 
treatment other than surgery only or W&S are at risk for higher distress. These results 
can help identify patients possibly in need of referral to professional psychosocial and/
or allied health care.
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INTRODUCTION
Patients confronted with a diagnosis of cancer face numerous stressors in the physical, 
emotional, social, practical and/or spiritual life domains [1,2]. Between 25 and 50% of 
cancer patients experience clinically elevated psychosocial distress for which profes-
sional care may be needed [3,4]. Distress has been recognized as the sixth vital sign 
after blood pressure, temperature, respiration, pulse, and pain, suggesting that distress 
screening should be part of conventional cancer care [5].
Appropriate screening and early identification of problems are essential to ensure 
that patients receive the psychosocial and/or allied professional health care they need 
[6-8]. During the last years, the need for psychosocial screening has been recognized 
and guidelines on systematic screening and distress management have been formulat-
ed by several professional organizations [9]. The Distress Thermometer (DT), originally 
developed in 1998 [10], showed to be a valuable tool in psychosocial screening of can-
cer patients [10-12]. The DT combined with the Problem List (PL) consisting of items 
covering the practical, social, emotional, spiritual and physical domains is central in the 
distress management guideline of the National Comprehensive Cancer Network [11], 
and its validated Dutch version in the Dutch guideline [13,14]. During the last few years, 
routine screening with the Dutch DT/PL has been implemented in many oncology clin-
ics in the Netherlands.
Since its development, the DT/PL have been validated in many countries world-
wide. The optimal DT cutoff score for identifying clinically distressed patients reported 
in the 27 studies found in the literature varied from no cutoff point found [15]), to ≥3 
[16,17], ≥4 [18-30], ≥5 [10,13,31-36], ≥6 [37] and ≥7 [38,39]. The Hospital Anxiety and 
Depression Scale (HADS) was used in 67% of the studies to determine optimal DT cutoff 
scores [13,16-22,24,25,28,29,31,34-38].
A reason for the differences in cutoff scores found in the literature may be type of 
cancer, besides possible cultural and methodological reasons [16]. It has been argued 
that much has to be learned about the instrument’s validity when applied in specific 
cancer populations [40]. Cancer patients should not be perceived as a homogeneous 
group concerning the psychosocial and physical difficulties they may experience [4,41]. 
Validation has mainly been performed in patient samples with varying cancer types. A 
consistent overrepresentation of breast cancer patients (≥30%) is present in the ma-
jority of these validation studies, including the Dutch [13,17,19,20,22,26,29,31,32,38
,39]. The high number of breast cancer patients may have exerted a significant effect 
on distress levels and cutoff estimates. Until now, it remains unclear whether distress 
2
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levels and DT cutoff scores depend on cancer type. Additionally, because of the more 
limited rule-in ability of the DT [3], knowledge of which patient’ socio-demographic 
and illness-related characteristics are associated with higher DT scores may support 
adequate identification of patients at risk for clinically elevated distress [4].
To our knowledge, no study has made a systematic attempt to identify optimal cut-
off scores, signaling clinically elevated distress, for different cancer types. The aim of 
the present study was two-fold: 1) to examine the hypothesis that distress levels and 
cutoff scores depend on cancer type and/or treatment; 2) to examine the effect of so-
cio-demographic and illness-related variables on patients’ perceived distress.
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METHODS
Patients
This study was conducted in the surgical, medical, gynecologic and urologic oncology 
departments of twenty-two hospitals in the Netherlands. Patients who were aware of 
their cancer diagnosis and treatment plan were approached for study participation. Eli-
gible patients were in a ‘wait and see’ (W&S) condition (prostate cancer patients only), 
under active treatment, or visited the hospital for follow-up after treatment comple-
tion. Patients had to be aged ≥18 years, physically and cognitively able to complete the 
questionnaire, and sufficiently fluent in Dutch.
Procedures
Study coordination was performed by the Comprehensive Cancer Center Netherlands, 
location Groningen (CCCN). All twenty-three hospitals in the North-Eastern CCCN re-
gion were approached and 19 agreed upon study participation. Three hospitals situat-
ed elsewhere in the Netherlands requested to participate. The study was performed 
according to the regulations of the medical ethical committee of the University Medical 
Centre Groningen and followed the ethical guidelines of the participating hospitals. 
Depending on the number of patients yearly diagnosed with cancer in a hospital (in-
formation gained from the Netherlands Cancer Registry, CCCN) between 30-300 ques-
tionnaires were handed out. All patients visiting the outpatient clinics meeting the in-
clusion criteria were invited by their physician or nurse for study participation. Patients 
willing to participate received written information about the study aims, procedures, 
contact information of the investigators, the questionnaire, an informed consent form, 
and a prepaid return envelope. Patients were recruited until all questionnaires were 
handed out which usually took between 2 to 4 weeks.
Measures
The following socio-demographic and illness-related characteristics were assessed 
through the self-report questionnaire: age, gender, marital status, children, education 
completed (range: primary (1) – university (6)), employment status (full-time job; part-
time job; self-employed; sickness/invalidity benefit; unemployed; unable to work; re-
tired; student; voluntary work), cancer type, date of diagnosis, treatment modalities 
and treatment phase (W&S, under active treatment, or in follow-up). Patients were 
placed in a curative or palliative treatment intent group by a medical oncologist on the 
basis of cancer type and treatment.
2
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Distress was measured using the Dutch DT/PL [11,13]. The DT consists of a single item 
that asks patients to indicate the amount of overall distress experienced during the 
past week on a 11-point scale. Scores range from 0-10 (no to extreme distress). The 
Dutch PL incorporates 47 items. Patients can indicate whether or not (yes/no) they 
experienced practical (7 items), family/social (3 items), emotional (10 items), religious/
spiritual (2 items) and physical problems (25 items). Patients were asked to rate from 
1-10 the amount of distress they experienced for each item in the problem list they 
answered ‘yes’. The last question of the questionnaire covered patients’ referral wish 
(yes, maybe or no) to a psychosocial (psychologist, psychiatrist, social or pastoral work-
er) or allied (physical therapist, dietician) health care professional [13].
The Hospital Anxiety and Depression scale (HADS) is a 14-item self-report question-
naire that assesses symptom severity of anxiety and depression [42]. The HADS has 
been used in many different populations, including cancer patients [42,43]. Its validity 
and reliability have been well-established. The questionnaire consists of two 7-item 
subscales: an anxiety and a depression subscale. Scores range from 0-21 for each sub-
scale with higher scores indicating higher levels of anxiety/depression. A score of ≥15 
has been indicated to be the ideal cutoff score representing clinically significant emo-
tional distress [42].
Data analysis
Descriptive analyses were calculated for the socio-demographic and illness-related var-
iables, the DT/PL and the HADS. PL subscale scores were computed by taking the mean 
of the total scores of the items within each subscale. If a patient had a missing value on a 
variable relevant for a specific analysis, he/she was not included in that analysis.
Receiver operating characteristics (ROC) analyses [44] were used to examine what 
DT score most adequately distinguished between HADS cases and non-cases. The HADS 
score of ≥15 implying caseness was used as the gold standard. Cutoff scores were es-
tablished on the optimal tradeoff between sensitivity and specificity values (sensitivi-
ty≥specifity). Separate ROC curves were computed for the different cancer types. Positive 
likelihood ratio’s (LR+), positive predictive values (PPV) and negative predictive values 
(NPV) were calculated for each cancer type’s optimal DT cutoff score. Cancer type was 
categorized into breast (including 7 men), prostate, digestive, lung, gynecologic, head/
neck, sarcoma/bone, hematologic, skin or urologic (other than prostate) cancer. The last 
group consisted of patients with other types of cancer (17 liver, 6 brain, 2 thyroid and 
2 multiple cancers). Statistical power software (PASS [45] showed a required sample of 
N≥45 to obtain an AUC of 0.80 with 80% power (DT≥5=20% [13], two-sided tests).
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Independent-samples t-test, one-way independent ANOVA’s, and Pearson’s correla-
tions were conducted to explore univariate effects on the DT. ANOVA’s were comput-
ed to examine the effect of cancer type on PL subscale scores. Small-sized effects[46] 
could be detected with 80% power for (two-sided) t-tests, correlations and ANOVA’s 
(d≥0.18-d≥0.24 (N2/N1=2-6), ρ=0.10 and f=0.09-f=0.12 (3-11 subgroups) respectively) 
with N=1100 (G*power [47]). Hochberg’s GT2 post-hoc tests were executed to cor-
rect for differences in sample sizes across cancer types, treatment types and phases. 
Welch F was reported in case of violation of the homogeneity of variance assumption. 
Socio-demographic and illness-related variables showing an univariate significant ef-
fect on the DT were entered into a hierarchical multiple regression analysis (first step). 
Previous research showed high distress levels in young and female patients [41,48] 
and low distress in prostate cancer patients [4,48,49] in the W&S [50]. Therefore, in-
teraction terms for age (centered scores)×gender and treatment intensity×cancer type 
were entered into the second step to examine the additional value over and above 
the main effects. Simple slope analyses were performed to interpret significant inter-
action effects. To estimate slopes for patients low and high in age values of –1SD and 
+1SD from the mean were used, respectively [51,52]. Power analyses (G*power [47]) 






A total of 2640 eligible patients were invited to participate in the study, of whom 1352 
returned the questionnaire (response=51%). Two patients were excluded because they 
were aged <18 years. Ten questionnaires were excluded due to data incompleteness. 
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Preliminary results
Patients’ mean DT score was 3.8 (SD=2.7); 41% scored ≥5. Most problems were experi-
enced in the emotional and physical domains. Fatigue (58%), physical fitness/condition 
(54%), tension/nervousness (41%), emotional control (37%), and sleep (36%) were re-
ported most frequently on the PL.
Univariate effect of cancer type on DT/PL
Cancer type had a significant effect on DT score, F(10,1186)=5.0, p<.001. Consequent 
Hochberg’s GT2 post-hoc tests showed that prostate cancer patients experienced sig-
nificantly less distress than patients with breast, digestive, lung, gynecologic, head/
neck and ‘other’ cancers (Table 2).
Significant univariate effects were found of cancer type on the practical, emotional, 
social and physical domains (Table 2). Hochberg’s GT2 analysis revealed that prostate 
cancer patients experienced less distress in the practical domain than breast, gyne-
cologic and sarcoma/bone cancer patients; in the emotional domain than breast and 
gynecologic cancer patients; and in the physical domain than breast, lung, digestive 
and ‘other’ cancers. Lung cancer patients reported significantly lower distress in the 
practical and social domains than breast cancer patients. Patients with ‘other’ cancers 
experienced more physical problems than head/neck and sarcoma/bone patients.
Cutoff scores
The ROC curve of breast cancer patients showed an area under the curve (AUC) of 0.82 
(95%CI 0.77-0.86). A cutoff score of 5 on the DT showed optimal diagnostic accuracy 
with correct classification of 85% of HADS cases (sensitivity) and 66% of HADS non-cas-
es (specificity). The corresponding LR+ was 2.48: breast cancer patients scoring ≥5 on 
the DT were 2.5 times more likely to be a HADS case than a HADS non-case. ROC curves 
of digestive, gynecologic and head/neck patients (AUC ranged between 0.72-0.84) also 
showed a cutoff score of 5. ROC analyses of prostate (AUC 0.77; 95%CI 0.62-0.92), 
sarcoma/bone (AUC 0.87; 95%CI 0.76-0.97) and lung cancer patients (AUC 0.80; 95%CI 
0.67-0.92) showed an optimal tradeoff between sensitivity and specificity at a score of 
4 (Table 3). However, analysis of the male lung cancer patients (N=55/78, 71%) showed 
an AUC of 0.80 (95%CI 0.66-0.95), sensitivity 75%, specificity 63%, resulting in a cutoff 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































Processed on: 13-12-2019 PDF page: 37
37
Effect of cancer and treatment type on distress





point Sensitivity Specificity LR+ PPV NPV
Breast 488 5 0.85 0.66 2.48 0.32 0.96
Prostate 147 4 0.86 0.76 3.56 0.28 0.98
Digestive 131 5 0.71 0.65 2.00 0.43 0.86
Lung  78 4 0.87 0.52 1.82 0.33 0.94
Gynecologic  73 5 0.92 0.69 2.94 0.37 0.98
Head/neck  72 5 0.77 0.63 2.06 0.35 0.91
Sarcoma/bone  49 4 1.00 0.65 2.86 0.42 1.00
 
Univariate effect of patient characteristics
Age, gender, children living at home, treatment phase, and treatment type significantly 
univariately affected the DT score (Table 1). Patients who were younger, female or had 
children living at home experienced higher distress levels than their counterparts. As 
for treatment phase, post-hoc test revealed significant differences between all phases: 
patients in the W&S condition had lowest scores and patients under active treatment 
had highest scores. Concerning treatment type, post-hoc tests showed that patients 
receiving surgery only, radiotherapy only and patients in the W&S condition report-
ed experiencing lower distress than patients undergoing surgery and chemotherapy; 
surgery, radiotherapy and chemotherapy; or chemotherapy and radiotherapy. Patients 
receiving chemotherapy only reported significantly higher distress than patients under-
going radiotherapy only and patients in the W&S condition.
Further inspection revealed that the 45 prostate cancer patients undergoing radi-
otherapy only reported significantly lower distress (M=1.9+2.0) than the 25 non-pros-
tate cancer patients undergoing radiotherapy only (M=4.0+2.1; t=4.0, p<.001). The 
mean distress score of this last patient group was similar to that of non-prostate cancer 
patients receiving other treatment types (p=1.0).
Multivariate model predicting DT score
The variable cancer type was dichotomized into prostate versus non-prostate cancer 
type. Treatment type was dichotomized into non-intensive (surgery only + prostate 
cancer patients in the W&S condition and those receiving radiotherapy only (66% of 
prostate cancer patients)) versus intensive treatment (all other treatment types + the 
remaining 34% prostate cancer patients) based on the results of previous analyses. 
2
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Multiple hierarchical regression analysis showed that 8% of the variance was explained 
by the variables included in the model (F=10.86, p<.001). Of the variables included in 
the first step, intensive treatment and having a non-prostate cancer type appeared to 
have a significant unique effect. The interaction terms of age×gender and treatment 
intensity×cancer type, entered in the second step, each had a significant independent 
effect on the DT score (Table 4).
Table 4. Hierarchical multiple regression analysis, final model (N=1151).
β R2 R2Ch FCh
Step 1 0.07  12.68***
Age  -0.03
Gender  -0.00
Children living at home  -0.03
Prostate cancer(y/n)  -0.17***
Treatment intensity  -0.10**
Under active treatment†  -0.05
Wait&see†  -0.00
Step 2 0.08 0.01  4.25*
Interaction age×gender  -0.12*




Simple slope analyses revealed a significant effect of age on distress in women (β=-.17, 
p<.001) but not in men (β=-.03, p=.57). Women’s mean distress level decreased from 
younger (DTmean=4.3) to older age (DTmean=3.4) whereas mean distress in men was com-
parable across ages (DTmean=3.5 younger age; DTmean=3.4 older age). Younger women’s 
distress was higher than that of younger men (β=.15, p<.01) but no gender difference was 
found at older age (β=.01, p=.84). Simple slopes of treatment intensity×prostate cancer 
showed significantly lower distress (β=-.17, p<.001) in non-intensively treated prostate 
cancer patients (DTmean=1.9) than in non-intensively treated non-prostate cancer patients 
(DTmean=3.2). The difference (β=-.05, p=.27) between intensively treated prostate cancer 
patients (DTmean=3.7) and intensively treated non-prostate cancer patients (DTmean=4.1) 
was not significant. Non-intensively treated cancer patients reported lower distress 
than intensively treated patients, both in prostate cancer patients (β=1.8, p<.001) and in 
non-prostate cancer patients (β=.86, p<.001).
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DISCUSSION
The current study aimed first to examine differences in distress levels and cutoff scores 
between patients diagnosed with different cancers. Prostate cancer patients reported 
experiencing less distress than patients with breast, digestive, lung, gynecologic, head/
neck and liver/brain/thyroid cancers. Also, a lower cutoff of ≥4 on the DT was found 
for prostate cancer patients than the cutoff of ≥5 for breast, digestive, gynecologic 
and head/neck cancer patients. Lower distress in prostate cancer patients compared 
to patients with other types of cancer has been reported previously [4,48,49,53]. Low-
er distress in prostate cancer patients seems to be partly treatment-related while not 
gender-related (see fifth paragraph in the discussion). Two thirds of the prostate cancer 
patients in the present study were in watchful waiting, or underwent surgery or radi-
otherapy only. These non-intensively treated prostate cancer patients reported low-
er distress than intensively treated prostate cancer patients and than intensively and 
non-intensively treated non-prostate cancer patients. In support of our findings, earlier 
studies reported lower distress in prostate cancer patients in watchful waiting [50] and 
lower quality of life in prostate cancer patients receiving hormonal treatment [54,55]. 
In sum, and in support of our first hypothesis, distress levels and cutoff scores seem to 
depend both on cancer and treatment type.
An explanation for the lower distress found in prostate cancer patients is that many 
prostate cancer patients receive the information that the disease will probably not be 
the cause of death [56]. Hence, patients may perceive their condition as chronic rather 
than as life-threatening. A further explanation might be that prostate cancer patients, 
particularly those treated non-intensively, experience less physical impairment due to 
illness-and treatment-related factors than patients with other cancer types [53]. This 
is supported by the present study’s finding that prostate cancer patients reported less 
problems in the physical, practical, and emotional domains than patients with other 
cancer types.
An optimal DT score of ≥4 was also obtained for lung and sarcoma/bone cancer pa-
tients. However, the limited ability (specificity 52%) to identify non-clinically distressed 
lung cancer patients when using a cutoff score of ≥4 should be noted. Analyses of male 
lung cancer patients showed a cutoff of ≥5 yielding a higher specificity value (63%). 
Similarly, the sensitivity value of sarcoma/bone cancer patients was suspiciously high 
(100%), possibly caused by the small number of patients included. Hence, it should be 
examined whether a cutoff score of ≥4 holds in studies that include larger samples of 
lung and sarcoma/bone cancer patients.
2
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The Dutch distress management guideline [14] stresses the importance of discussing 
the DT/PL response pattern and appropriate referral of patients scoring above the DT’s 
cutoff. We would recommend to always discuss the response pattern with a patient, us-
ing the cutoff score (either ≥4 or ≥5 depending on cancer type and treatment intensity) 
as a first screen. A DT score below the cutoff does not exclude that a patient may suffer 
greatly from a specific problem for which referral may be necessary.
The second aim was to study the effect of socio-demographic and illness-related 
variables on distress. In addition to the effects of cancer type and treatment intensity, 
multivariate analyses showed higher distress levels in younger women as compared to 
younger men, older men and older women. Other studies [4,48,57] including one using 
the DT [58], found that age or gender were associated with higher distress. The present 
study shows that it is the combination of gender and age that matters. It has been sug-
gested that younger women respond differently to cancer than older women possibly 
due to personal and familial challenges that accompany an earlier life stage [59]. Many 
young women are highly involved in child-rearing and/or a professional career. Addi-
tionally, disfigurement of the body, sudden menopause, decreases in libido and vaginal 
dryness may be of great impact on young women’s (sexual) relationships [48,59].
Only eight percent of the variance in patients’ distress levels was explained by the 
variables included in the model suggesting that cancer, treatment type and age/gender 
have limited effect on patient reported distress levels. Other variables such as person-
ality, perceived control and social support [60-62] may play a greater role. The effect 
of such characteristics should be examined in addition to the risk variables identified 
in the present study.
The DT has been identified as a valid and effective tool in ruling out clinically-ele-
vated distress [12,58]. The rule-in ability is more limited and consequently, it has been 
recommended not to use the DT alone [3,12]. As such, the higher distress levels in 
non-prostate cancer patients, patients receiving more intensive treatment and younger 
women found in the present study may assist in the identification of patients at risk of 
developing clinically elevated distress and can further guide clinical decision making of 
whom to refer to professional psychosocial and/or allied health care.
Distress screening, as performed in the present study, is a vital component of 
distress management though not valuable in itself [58]. A future challenge is to con-
duct studies examining the effectiveness of distress management programs following 
screening [1,38,63] with special need for randomized controlled trials [58]. Distress 
screening and management programs should both be effective and efficient. Consider-
ing the growing number of cancer patients, computer-based programs seem a promis-
538881-L-sub01-bw-Admiraal
Processed on: 13-12-2019 PDF page: 41
41
Effect of cancer and treatment type on distress
ing venue for future distress screening and management [48,64].
The current study had some limitations. ROC analyses for some cancer types could 
not be performed or were of lower quality due to small sample sizes. Secondly, the 
HADS and the DT are not fully congruent [13]. The HADS questionnaire measures anx-
iety and depression whereas the DT more broadly assesses distress covering practi-
cal, social, emotional, spiritual and physical complaints. The finding that more patients 
scored above the DT cutoff than above the HADS cutoff reflects the DT’s multidimen-
sional nature. Thirdly, the response rate was 51% which may affect generalizability. No 
information was available from non-respondents because patients were approached 
for participation by their health care provider in the hospital and anonymous to the 
researchers. However, a large population of cancer patients was included varying in 
socio-demographic and illness-related characteristics and in distress, thus making com-
parisons possible.
Other clear advantages can be noted. The current study was the first to examine 
cutoff scores for separate cancer types. ROC analyses displayed clear cutoff scores and 
satisfying sensitivity and specificity estimates for a number of cancer types, underlining 
the value of our findings. Finally, we could identify patient’ risk factors for high distress 
which can be important in the process of clinical decisions making.
In summary, the distress level and cutoff score in prostate cancer patients appear 
to be lower than in patients with other cancer types. Particularly prostate cancer pa-
tients who underwent surgery or radiotherapy only or who were in the W&S condition 
reported low distress. Patients receiving treatment other than surgery only and young-
er women are at risk for higher distress. Screening for distress and knowledge of risk 
factors may facilitate identification of clinically distressed patients possibly in need of 
additional psychosocial and/or allied professional health care.
2
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Background: The present study’s aim was to examine effects of cancer patients’ 
perceived distress and problems, socio-demographic and illness-related variables, and 
social support sufficiency on referral wish.
Methods: A cross-sectional group of 1340 patients (response=51%) completed a 
questionnaire consisting of: the Dutch version of the Distress Thermometer and Problem 
List (PL), including the referral wish question; and questions on socio-demographic 
and illness-related variables and perceived social support sufficiency. Univariate and 
multivariate analyses were performed to investigate the effects of these variables on 
patients’ referral wish.
Results: Of the patients who completed the referral wish question (n=1297), 13% 
wished and 21% considered a referral, while 66% did not want a referral. Univariate 
analyses showed that, in comparison to patients not having a referral wish, those 
having a (maybe) wish were more distressed, reporting more problems in all PL 
domains, younger, more likely not to have children or children living at home, higher 
educated, more likely to be employed, under active treatment or recently diagnosed, 
receiving more intensive treatment, and more likely to perceive support received to be 
insufficient. A final ordinal logistic regression analysis showed independent effects of 
distress, practical and emotional problems, age, and treatment phase on referral wish 
(χ2(6)=205.9; p<0.001; Nagelkerke’s R2=0.24).
Conclusions: A third of the patients (maybe) wished a referral. Knowledge of risk 
variables (particularly increased distress, experience of more practical and emotional 
problems, younger age, and receiving active treatment or recently diagnosed) may 
support the identification of patients at increased need of additional health care 
services.
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INTRODUCTION
Distress is frequently encountered by cancer patients during treatment and follow-up. 
Between 30% and 40% of cancer patients experience clinically elevated psychosocial 
distress for which professional care may be needed [1,2]. Elevated distress levels have 
been associated with reduced health-related quality of life [3,4], low satisfaction with 
medical care [5], and decreased treatment adherence [6]. Therefore, guidelines were 
developed by professional organizations [7,8] to ensure that distress management 
would be an integral component of oncology practice.
According to the Dutch guideline “Detection of Need for Care”, appropriate distress 
management entails several steps: 1) completion of the Dutch version of the Distress 
Thermometer (DT) and Problem List (PL) to detect distress level, problems or unmet 
needs underlying the distress, and a patient’s referral wish to professional health care 
services; 2) discussion of patients’ response patterns on the DT/PL, and; 3) referral to 
appropriate services, if needed or wished, for treatment of identified problems [9].
A number of studies provide insight into factors associated with distress or unmet 
needs (e.g. [10-12]). However, the literature on factors associated with patients’ refer-
ral wish to psychosocial and paramedical health care services is relatively sparse and 
results are mostly contradictory. It is important to identify predictors of referral wish 
since knowledge of predictors may aid in the identification of patients who are willing 
to accept a referral [13].
Several studies showed that distress is significantly related to referral wish [12-17] 
but other studies found no such relationship [18,19]. Younger age has been associated 
consistently with an increased likelihood that patients desire a referral [15-17,19,20]. 
However, no consistent relationship with referral wish was found of other socio-demo-
graphic variables such as educational level and relationship status [15-17,19,20]. Also, 
the literature is inconclusive as to the effect of illness-related variables, such as type of 
treatment received [15,19]. The heterogeneity in study outcomes (desire for psycho-
logical support [17,19], need for services [15], need for help [13], actual referral [20], 
or access of services [16]) and measurement instruments used may account for the 
different findings. Additionally, some studies specifically focused on a single treatment 
(patients receiving chemotherapy [13]), time period (newly diagnosed [16]), or patient 
group (breast cancer [17], metastatic lung or gastro-intestinal cancer [20]) limiting the 
generalizability of the findings. All in all, no conclusive evidence is available on the ef-
fects of distress or socio-demographic and illness-related factors on referral wish.
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Patients who perceive their social environment as supportive report a higher quality 
of life, better psychological health, less supportive health care needs or are less often 
referred [20-23]. Therefore, we hypothesize that patients who experience sufficient 
social support are less likely to have a referral wish for additional psychosocial and/or 
paramedical health care than patients who perceive the social support they receive as 
insufficient.
The present study aims to contribute to our understanding of which patients would 
be more likely to wish a referral. To our knowledge, this is the first study including a 
large heterogeneous sample of cancer patients and a diverse set of variables to ex-
amine its effects on referral wish. This will enable us to draw more firm conclusions. 
The objectives of the current study were: (1) to examine associations between cancer 
patients’ referral wish, patients’ distress and underlying problems; (2) to investigate as-
sociations between referral wish and socio-demographic and illness-related variables 
and perceived social support sufficiency; and (3) to study unique effects of variables 
significantly affecting referral wish.
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METHODS
Patients and procedures
Patients aware of their cancer diagnosis and treatment plan, aged ≥18 years, physically 
and cognitively able to complete the questionnaire, and sufficiently fluent in Dutch, 
were approached for study participation irrespective of time since diagnosis, intent, 
phase and type of treatment. All 23 hospitals in the North-Eastern region of the Neth-
erlands were approached. Nineteen agreed upon study participation. Three hospitals 
situated elsewhere in the Netherlands requested to participate. Staff from surgical, 
medical, gynecologic and/or urologic outpatient oncology clinics recruited patients, 
consecutively visiting these clinics, for the study. Consenters were given the question-
naire to complete at home and return anonymously to the Netherlands Comprehen-
sive Cancer Organisation (IKNL), who coordinated the study. Consequently, question-
naire responses were not discussed with patients. The study was performed according 
to the regulations of the medical ethical committee of the University Medical Centre 
Groningen and followed the ethical guidelines of the participating hospitals. Study pro-
cedures and patients have been described in detail elsewhere [10].
Measures
Socio-demographic (age, gender, relationship status, children, highest education level 
completed (range from 1=primary school only to 7=university), employment status, 
and illness-related characteristics (cancer type, date of diagnosis, treatment type, 
treatment phase) were assessed through self-report questions. A medical oncologist 
placed patients in a curative or palliative treatment intent group on the basis of cancer 
type and treatment.
Perceived social support sufficiency was assessed by a single item. Patients were 
asked whether they perceived the support they had received from their family and 
broader social environment had been sufficient (yes/no).
The self-report Dutch DT/PL was used to assess distress, problems experienced and 
referral wish [8,14]. The DT is a single item asking patients to indicate the amount of 
distress experienced during the past week on a 11-point scale, ranging from 0-10 (no 
to extreme distress). The DT cutoff score for identifying clinically distressed patients 
was ≥5 [14]. On the Dutch PL, patients can indicate whether or not (yes/no) they ex-
perienced practical (7 items), family/social (3 items), emotional (10 items), religious/
spiritual (2 items) and physical problems (25 items). Patients were asked to rate from 
1-10 the amount of distress they experienced for each item in the problem list they 
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answered ‘yes’. The last question of the Dutch DT/PL covers patients’ referral wish to 
a psychosocial or paramedical health care professional [14]. Answer categories were: 
‘yes’, ‘maybe’ or ‘no’ (Appendix 11).
Analysis
Descriptive analyses were calculated for socio-demographic and illness-related varia-
bles, social support sufficiency, and the DT/PL. Relationship status was dichotomized into 
‘relationship’ (married and cohabiting patients) and ‘no relationship’ (single, widowed, 
divorced and LAT (=living-apart-together)) [24]. Treatment type was dichotomized into 
non-intensive (surgery only and patients in the ‘watchful waiting’ condition) versus in-
tensive treatment (any other type or combination of treatment) [10,14]. The ‘watchful 
waiting’ treatment phase group was merged with the ‘follow-up’ group and the ‘recently 
diagnosed’ with the ‘under active treatment’ group in further analyses to avoid expected 
values <5 and because responses on the referral wish question in the combined groups 
were comparable. PL domain scores were computed by adding the scores of the items 
within each domain.
Chi-square tests, one-way ANOVA’s and Kruskal-Wallis tests were performed to ex-
plore univariate effects of the variables on referral wish. When a chi-square was signif-
icant, post-hoc pairwise comparisons of column proportions with Bonferroni adjusted 
p-values were used to examine significant differences between referral wish groups. 
Significant Kruskal-Wallis tests were followed by Mann-Whitney U-tests with post-hoc 
Bonferroni corrections.
Variables showing a univariate significant effect on referral wish were entered into 
two separate multivariate ordinal regression analyses to examine independent effects 
on referral wish: the first including the DT and PL subscales, and the second including the 
socio-demographic and illness-related variables and social support sufficiency. Variables 
with the highest p-value were removed in a stepwise fashion until all included variables 
added significantly to the model (p≤0.05). Significant variables from these two analyses 
were entered into a final model (forced entry method). The negative log-log link function 
was used to calculate the effect of the variables on referral wish since lower categories 
(no vs. maybe and maybe vs. yes) were more probable [25]. The coefficients (exp(-B)) of 
this link function represent the ratio of two log transformed cumulative probabilities. A 
positive B indicates a higher probability of referral wish for higher values of the explana-
tory variable. Statistical model assumptions were checked for violations (e.g. adequacy of 
1 Appendix 1 can be found in Appendix A in this thesis
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expected frequencies, absence of multicollinearity and proportional odds). Nagelkerke R2 




As reported earlier [10], the response rate was 51%. Data of 1340 patients were ana-
lyzed. Table 1 depicts patients’ characteristics and the univariate effects of these vari-
ables on referral wish. Of the respondents to the referral wish question (N=1297), 13% 
wished (N=167), 21% considered (N=272), and 66% (N=858) did not want a referral to 
a psychosocial or paramedical health care professional.
Table 1. Patients’ characteristics and univariate effects on patients’ referral wish (N varied 
between 1195 and 1297 in analyses)
Characteristics
Referral wish
No Maybe Yes Test statistic
Referral wish (N(%)) 858 (66) 272 (21) 167 (13)












































































































































Percentages may vary between 99-101% due to rounding
F=ANOVA; X2=Chi-square; H=Kruskal-Wallis
*p<0.05; **p<0.01; ***p<0.001
Groups with different superscripts differ significantly from each other
IQR=Interquartile range
^Other=hematologic(39), skin(27), urologic(22), liver(17), brain(5), thyroid(2), unknown(2)
Univariate effect of distress and problems on referral wish
Median DT scores differed significantly between all three referral wish groups: patients 
indicating a referral wish had the highest median DT score and patients having no refer-
ral wish had the lowest. Also, referral wish and scoring under/above the DT cutoff were 
associated (Table 2). Pairwise comparisons showed that the proportion of patients with 
a DT score above the cutoff who (maybe) wished a referral was significantly higher than 
the proportion of patients who scored under the cutoff.
Mann-Whitney post-hoc tests showed differences between all three referral wish 
groups in the practical domain of the PL. In the remaining domains, differences were 
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found between patients who wished or considered a referral and patients not wishing 
a referral (Table 2).
Table 2. Descriptives of DT/PL and univariate effects of DT/PL on referral wish (N varied between 
1081 and 1267 in analyses)
Referral wish
No Maybe Yes Test statistic
DT
 Median(IQR) (r=0-10) 3 (1-5)a 5 (3-7)b 6 (3-7)c H=147.0***
 N scoring ≥5(%) 245 (50) 144 (29) 103 (21)
χ2=97.7***
 N scoring <5(%) 540 (77) 111 (16) 52 (7)
PL subscales (Median(IQR))
 Practical (r=0-58) 0 (0-3)a 3 (0-8)b 6 (0-14)c H=125.7***
 Social (r=0-30) 0 (0-0)a 0 (0-3)b 0 (0-5)b H=103.3***
 Emotional (r=0-84) 3 (0-11)a 14 (6-31)b 21 (9-38)b H=198.2***
 Spiritual (r=0-18) 0 (0-0)a 0 (0-3)b 0 (0-3)b H=72.7***




Groups with different superscripts differ significantly from each other
Univariate effect of patient characteristics on referral wish
Eight variables were significantly associated with referral wish (Table 1). Patients who 
were younger or had higher education were more likely to consider or wish a referral 
than their counterparts. Patients who had no children or were employed were signif-
icantly more likely to consider a referral and less likely to have no referral wish than 
patients with children or who were not employed. A higher proportion of patients who 
had children living at home expressed a referral wish than patients who had no children 
living at home.
Regarding treatment phase, a higher proportion of patients who were in follow-up 
or watchful waiting did not want a referral while a higher proportion of patients who 
were under active treatment or recently diagnosed did express a referral wish. Patients 
who received intensive treatment were significantly more likely to express a referral 
wish and less likely to express no wish than patients who received non-intensive treat-
ment.
Lastly, significantly more patients who experienced insufficient social support (may-
3
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be) wished a referral and fewer had no referral wish than patients who experienced 
sufficient support.
Multivariate analysis
The test of parallel lines evaluating the proportional odds assumption was satisfied for 
the ordinal regression analyses, reflecting the appropriateness of the negative log-log 
ordinal models. No serious violations of the adequacy of expected frequencies were 
observed.
The first regression analysis, including the DT and all PL subscales, showed inde-
pendent significant effects of three variables: patients reporting a higher score on the 
DT, and on the practical and emotional domains were more likely to consider or wish 
a referral (χ2(3)=201.3, p<.001; Nagelkerke’s R2=0.23) (Table 3). Of the eight variables 
included in the second regression analysis, three showed a unique significant effect on 
referral wish (Table 3). Patients who were younger, who were under active treatment 
or recently diagnosed, and those who experienced insufficient social support were 
more likely to consider or wish a referral (χ2(3)=76.2; p<0.001; Nagelkerke’s R2=0.07). 
The final model (χ2(6)=205.9; p<0.001; Nagelkerke’s R2=0.24) showed independent sig-
nificant effects of distress, practical and emotional problems, age, and treatment phase 
(Table 4).
Table 3. Separate ordinal regression analyses including: 1) the DT/PL (N=977) and; 2) socio-
demographics, illness-related characteristics and social support sufficiency univariately 
associated with referral wish^ (N=1228)
Variables Estimate Standard Error
DT   0.114*** 0.028
PL subscales
 Practical   0.022** 0.007




 Recently diagnosed/under active treatment 0.357*** 0.097
Social support sufficiency
 Noa
 Yes -0.899*** 0.141
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Table 4. Final ordinal regression analysis (N=957)
Variables Estimate Standard Error
DT 0.101*** 0.029
PL subscales
 Practical 0.020** 0.007




 Recently diagnosed/under active treatment 0.263* 0.115
Social support sufficiency
 Noa









The current study, including a large heterogeneous sample of cancer patients, exam-
ined effects of perceived distress and problems, socio-demographic and illness-relat-
ed variables, and social support sufficiency on referral wish. Independent significant 
effects of five variables were found, namely patients who experienced more distress, 
more problems in the practical and/or emotional domain, who were under active 
treatment or recently diagnosed, and/or those who were younger were more likely to 
express a referral wish. Nine additional variables were univariately related: patients ex-
periencing more problems in the social, spiritual and physical domains were more likely 
to have a (maybe) referral wish, as were patients who had no children or children living 
at home, who had completed a higher educational level, were unemployed, received 
intensive treatment, and who indicated that the social support they had received was 
insufficient.
The finding that distress level was associated with referral wish has been observed 
previously [13,27,28], also in smaller heterogeneous Dutch samples [12,14,15]. The 
likelihood that a patient with a high distress score (DT≥5) expressed a referral wish 
appeared to be three times as high as that in a patient with a low score. Distress level 
and emotional and practical problems appeared to be more powerful predictors of re-
ferral wish than socio-demographic or illness-related variables and social support suffi-
ciency. This has not been reported before and suggests that a DT/PL response pattern 
provides more information when deciding on whom to refer than socio-demographic 
or illness-related variables and support sufficiency. However, distress was not decisive. 
Half of the high distressed patients reported no referral wish, while a small but sub-
stantial percentage with low distress did express a referral wish. Similar findings were 
reported in previous studies [14,15]. These results suggest that screening for distress is 
helpful in identifying patients with high symptom burden but insufficient to determine 
who would desire or need additional care, even when used in combination with the 
risk variables identified in the present study. This underlines the importance of discuss-
ing DT/PL responses and referral wish with all patients, regardless of their distress level, 
as recommended in the Dutch guideline [9].
Discussing responses may reveal why patients who experience high distress report 
no referral wish. A common reason for not desiring a referral is a preference to rely on 
informal social support such as family and friends [29,30]. This was also supported by 
our findings that support sufficiency was related to a decreased referral wish. Secondly, 
patients may not be aware of available services. A recent review study showed that 
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19% of cancer patients lacked information regarding availability of various health care 
services [31]. Therefore, patients should be well informed about the various sources 
of additional care that they could be referred to for the specific psychosocial, physical, 
spiritual and practical concerns they experience. Thirdly, patients may question wheth-
er the (intensity of) distress they experience is normal. Normalizing feelings and point-
ing out problems usually experienced by fellow cancer patients may decrease distress. 
Finally, patients may not wish a referral because of concerns about stigma. About 10% of 
patients reported stigma as a reason for not wanting psychosocial care [31]. De-stigma-
tizing psychosocial care may encourage patients with unmet needs to accept such care. 
Communication between a clinical staff member and a patient may uncover reasons such 
as mentioned above, possibly leading to referral and uptake of professional care. Similar-
ly, discussion with patients reporting an overall low level of distress may reveal why and 
for which specific problem a patient requires a referral. Asking patients directly about 
the need for services, as has been suggested as a substitute for screening for distress, 
would provide insufficient information. We argue for a process that includes collecting 
information from patients about distress, problems and need for referral and discussing 
responses with patients to adequately decide whether one should refer and to whom.
Distress associated with underlying problems in all PL domains was related to referral 
wish. The only other study that, to the authors’ knowledge, examined relationships be-
tween the PL and referral wish multivariately found that emotional problems were asso-
ciated with desiring help in lung cancer patients [27]. In contrast, we found that practical 
problems also had a unique effect. An explanation may be that lung cancer patients re-
ported having fewer practical problems than patients diagnosed with other cancers [10]. 
Studies not using the PL showed that referral (wish) was related to emotional [13,19,20], 
marital [19], physical [19], and spiritual [20] difficulties, which support our results.
Additionally, several socio-demographic and illness related variables were associated 
with referral wish. Similar to earlier research, we found that younger patients were more 
likely to wish a referral [15,19,20,32]. In confirmation of our hypothesis, we found that 
the experience of insufficient social support was among the most important predictors 
of referral wish in the model including socio-demographic and illness-related variables. 
Patients may receive social support from different sources [33,34]. Our study shows that 
having adult children (those not living at home) was associated with a lower likelihood 
of desiring a referral suggesting that adult children may be a significant source of social 
support. Conversely, parents who had children living at home (age being a potential con-
founder) were more likely to wish a referral. Patients who face cancer treatment while 
having dependent children at home are often confronted with multiple problems possi-
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bly causing distress [35]. For example, parents may feel unable to protect their children 
from being forced to deal with their parent’s cancer. Also, maintaining household rou-
tines is often difficult and may require that children or others help with tasks traditionally 
performed by the parent [36]. Future research is required to establish the exact role of 
different social support sources and perceived sufficiency with regard to referral wish. 
Particularly because when including the DT and the practical and emotional problem do-
mains, the contribution of social support sufficiency on referral wish became non-signif-
icant. It may well be that distress as measured with the DT encompasses distress associ-
ated with perceived social support insufficiency from sources such as mentioned above.
Of the illness-related variables included in the current study, treatment phase affect-
ed referral wish most strongly. Our results show that health care professionals should 
pay particular attention to the psychosocial or paramedical health care needs of patients 
during cancer treatment, while it has often been suggested that attention should be par-
ticularly focused on the first year after treatment completion [37].
Considering the multivariate model, the pseudo R2 was relatively low indicating that 
model fit can be improved by inclusion of other, possibly more relevant, variables. For 
example, future research may examine the effect of previous (negative) encounters with 
health care services and patients’ perceived benefit. These variables have been suggest-
ed as significant barriers in the delivery and uptake of health care services [16,30]. Identi-
fication of additional variables may further increase insight into determinants of patients’ 
referral wish.
Some limitations of the current study should be noted. The design of the study was 
cross-sectional. Consequently, we should be careful with conclusions regarding causality. 
Secondly, social support sufficiency was assessed with a single item. Questionnaires that 
measure perceived social support using multiple items and answer categories may pro-
vide a finer-grained picture of patients’ perceived social support sufficiency. However, the 
finding that perceived social support sufficiency differed between all three referral wish 
groups reflects the adequacy of our social support measure. Thirdly, the response rate 
(51%) was relatively low. No information was available from non-respondents because 
patients were approached for participation by their health care provider in the hospital 
and thus, anonymous to the researchers. Finally, women (62.6%) were overrepresented 
as were breast cancer patients (43.3%) considering 10-year prevalence in the Nether-
lands (53% and 22%, respectively [38]). This may have biased the results. However, nei-
ther gender nor cancer type were found to affect referral wish.
The current study had several strengths. The study used a large heterogeneous sam-
ple of cancer patients which enabled us to investigate possible effects of a large number 
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of variables on referral wish. Important differences were detected between the referral 
wish groups on a number of variables which may help health care providers to identify 
patients with a possible desire for additional health care.
The current study provides valuable information for clinical practise. To adequately 
manage cancer patients’ distress, we recommend health care professionals to be particu-
larly attentive to patients who report high distress and underlying emotional and prac-
tical problems, to younger patients, and to patients who currently receive treatment, 
because these patients seem to have an increased desire for a referral. Future research 
may focus on the effects and cost-effectiveness of a distress screening process, consist-
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Purpose: We examined distress levels, problems, referral wish and supportive health 
care use in a cross-sectional group of breast cancer survivors at two-time points with 
a one-year time interval. Also, factors related to continuing elevated distress were 
explored.
Methods: Breast cancer survivors, 1-5 years after chemotherapy completion, filled in 
the Dutch Distress Thermometer/Problem List (DT/PL) and questions on background 
characteristics at study inclusion (T1). DT/PL responses and health care use were 
discussed during semi-structured interviews. One year later, re-assessment took place 
(T2). The data were analyzed by descriptive and univariate analyses. Continuing elevated 
distress was defined as a DT score ≥5 at T1 and T2.
Results: Seventy-three survivors completed all questionnaires (response=84.6%). 
Eighteen (25%) experienced continuing elevated distress. Fatigue (T1 N=48 (66%); T2 
N=41 (56%)) and lack of physical fitness (T1 N=44 (60%); T2 N=36 (49%)) were most 
often reported. Time since diagnosis, health care use, and practical, social, emotional 
and physical problems were significantly associated with continuing elevated distress. 
Between diagnosis and T1, 42 (67%) used supportive healthcare services, mostly a 
psychologist and/or a physical/lymphedema therapist, and between T1-T2, 39 (53%) 
did. At T1, 8 (11%) expressed a referral wish and at T2, 11 (16%) did.
Conclusions: Screening and management of distress, problems and referral wish are 
important, even years after chemotherapy completion as a substantial proportion of 
breast cancer survivors continue to report elevated distress and problems. Special 
attention should be paid to survivors reporting physical problems, especially fatigue and 
lack of physical fitness, since these problems are most strongly related to continuing 
elevated distress.
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INTRODUCTION
Breast cancer is the most prevalent cancer in women worldwide [1]. Due to earlier diag-
nosis and advances in treatment, the five-year survival rate of breast cancer increased 
from 74 to 88% between 1981 and 2015 in the Netherlands [2]. With the growing num-
ber of breast cancer survivors, understanding of not only physical but also psychosocial 
functioning beyond diagnosis and treatment is essential for optimal survivorship care 
for this population.
Receiving a diagnosis of cancer and undergoing treatment poses challenges to sur-
vivors’ coping abilities. Survivors can experience tumor- or treatment-related physical 
difficulties such as fatigue, insomnia, and sexuality-related problems, and these prob-
lems may persist into longer-term survivorship [3-6]. Additionally, they may face emo-
tional, social, spiritual and/or practical problems [7-9].
The problems patients experience altogether are often referred to as ‘distress’ [10]. 
According to the transactional model of stress and coping of Lazarus and Folkman 
(1984), distress arises when an individual appraises that the demands of the stressor 
(e.g. cancer) exceed personal resources (the survivor’s ability to cope with cancer) [11]. 
Distress has been associated with reduced health-related quality of life [12,13], low 
satisfaction with medical care [14], and decreased treatment adherence [15]. Distress 
seems transient for most cancer survivors, but 15-21% of the survivors report stable 
high levels of distress up to 15 months post-diagnosis [16,17]. Consequently, it has 
been recommended to routinely screen for distress in cancer survivors to detect prob-
lems for which referral may be indicated. The National Comprehensive Cancer Network 
(NCCN, US) guideline for distress management was the first to recommend to screen all 
cancer patients with the Distress Thermometer (DT), a questionnaire specifically devel-
oped for cancer patients [10]. The NCCN also advises to use a Problem List (PL) that in-
vestigates which problem(s) in the practical, social, emotional, spiritual and/or physical 
domain underlie the reported level of distress. The DT in combination with the PL has a 
good reliability and internal consistency [18]. A meta-analysis including 42 studies from 
20 countries, including 14,808 cancer patients varying in cancer and treatment type, 
showed that the DT is a highly useful and valid screening tool to detect distress [19].
The Dutch guideline on screening and monitoring distress describes a process that 
encompasses: 1) completion of the Dutch version of the DT/PL, including a question 
on referral wish; 2) discussion of the completed DT/PL with patients, and (3) referral to 
appropriate healthcare services if needed or wished [20]. Following the stress-coping 
model of Lazarus and Folkman, survivors should be approached on how to optimize 
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their ability to cope and reduce their burden. The Dutch guideline describes a pro-
cess that is in line with this stress-coping approach. Adequate referral to supportive 
health care services after exploring survivors’ referral wish can aid in enhancing effec-
tive coping strategies and reducing the burden of the problems experienced [20]. Also, 
a screening process coupled with discussion and referral according to pre-determined 
pathways showed to be more effective with respect to doctor-patient communication 
and number of referrals than a screening process without these components [21-23].
Although the DT/PL has been recommended as the preferred tool for screening 
[24], little is known about DT/PL responses of breast cancer survivors who are beyond 
the first year after completion of primary treatment i.e. longer-term cancer survivors. 
Samples often include a mixture of survivors who are within the first year after primary 
treatment (re-entry phase [6]), long-term survivors (5+ years after diagnosis [25]) and 
survivors who are in between (longer-term survivors). This makes it difficult to gain in-
sight into the severity of distress, nature of problems, and referral wish of longer-term 
survivors [26-28]. Additionally, several studies examined the course of distress over 
time in breast cancer survivors who were within the first 15 months after diagnosis 
[17,29]. However, no studies are known assessing DT/PL responses over time in longer-
term (breast) cancer survivors. As longer-term breast cancer survivors may suffer from 
lingering emotional and physical problems (e.g. [3]), longitudinal studies may provide 
important information about the prevalence of distress and the underlying problems 
over time. Also, knowledge about supportive health care use and referral wish can fur-
ther increase insight into their needs.
The present study aims to contribute to our understanding of (clinically elevated) 
distress levels, problems, referral wish and health care use in longer-term breast can-
cer survivors over a one-year time period. Moreover, we explored which socio-demo-
graphic and illness-related variables and underlying problems were associated with 
continuing elevated distress.
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METHODS
Patients
Survivors were recruited from the outpatient clinic of the Department of Medical On-
cology of the University Medical Center Groningen (UMCG). Female breast cancer sur-
vivors who consecutively visited their medical oncologist for a routine follow-up visit 
and who had completed adjuvant chemotherapy 1-5 years earlier were invited to par-
ticipate (longer-term survivors). Eligibility criteria were: age ≥18 years, stage I-III breast 
cancer, no recurrent cancer, physically and cognitively able to complete a questionnaire 
and be interviewed, and sufficiently fluent in Dutch. The study was approved by the 
medical ethical committee of the UMCG.
Procedures
Eligible survivors received a letter at home with information about study aims and pro-
cedures, the questionnaire, an informed consent form and contact information of the 
investigators, one week before the routine follow-up visit. Survivors deciding to partici-
pate were requested to return the completed informed consent form and questionnaire 
in a prepaid return envelope to the UMCG before the visit (T1). Informed consent was 
obtained from all individual survivors included in the study. Immediately after the rou-
tine follow-up visit, enrolled survivors received a semi-structured interview (±20 min) 
with a specially trained oncology nurse or research psychologist in which responses on 
the DT/PL were discussed, brief psycho-education was provided (in case of problems), 
the need for a referral to additional supportive care services was explored and sup-
portive health care use since diagnosis was assessed (first cross-sectional assessment; 
T1). Single sessions (e.g. intake) with a health care professional were not considered as 
care. Survivors expressing a referral wish were referred to a relevant health care pro-
fessional or were instructed how to access the health care service that was requested.
The DT/PL was sent to participating survivors 1 year later together with an invitation 
for a second interview (second cross-sectional assessment; T2). Survivors who forgot to 
return the DT/PL or who were not scheduled for a follow-up visit (to a medical, surgical 
or radiation oncologist) 1 year later were offered an interview by telephone. Up to 
three attempts by phone were made to contact survivors who did not return the DT/PL.
Measures
Self-report questions assessed the following socio-demographic characteristics at T1: 
age, marital status, presence of children, educational level (range: primary (1)-univer-
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sity (6)), and employment status (employed for wages; not-employed). Illness-related 
characteristics (date of diagnosis, pTNM-classification, cancer stage (I-III, derived from 
pTNM-classification), medical treatment, and date of completion of last chemotherapy 
cycle were collected from the survivors’ medical records.
Distress, problems and referral wish were measured using the Dutch DT/PL [8,10], 
at T1 and T2. The DT consists of a single item that asks cancer survivors to indicate 
the amount of overall distress experienced during the past week on an 11-point scale 
(0-10; no to extreme distress). The Dutch DT/PL has been validated for cancer patients 
with different diagnoses and treatments [8,9]. A DT cutoff score of ≥5 represents clini-
cally elevated distress in Dutch breast cancer survivors. The sensitivity was 0.85, speci-
ficity 0.66, positive predictive value 0.32 and negative predictive value 0.96 [9]. On the 
47-item PL, cancer survivors can indicate whether or not (yes/no) they experienced 
practical, family/social, emotional, religious/spiritual, and physical problems. Survivors 
were asked to rate from 1-10 the amount of distress they experienced for each item in 
the PL they answered ‘yes’. Internal consistency and reliability of the PL is good (Cron-
bach’s alpha=0.90). Lastly, the questionnaire assesses cancer survivors’ referral wish 
(yes, maybe or no) to a health care professional (psychologist, social or pastoral worker, 
oncology nurse, physical therapist or dietician), peer support from a fellow patient, 
and/or to other types of health care [8].
During the interview at T1 and T2, patients were asked whether they had received 
care from a psychologist, social or pastoral worker, sexologist, physical therapist, 
lymphedema therapist, dietician and/or whether they were enrolled in a rehabilitation 
program combining physical and cognitive-behavioral therapy. Uptake of other types of 
health care was also explored.
Data analysis
The percentage of missing values ranged from 0 to 11.7%. Missing data patterns were 
examined with Little’s missing completely at random test with a chi-square statistic 
(p<.05), and descriptive analyses, i.e., separate-variance t-tests, cross tabulations, and 
a tabulated pattern table. The results showed that the data could be assumed to be 
missing at random, i.e. missingness was predicted by variables that were part of the 
dataset. Five imputations were generated for the missing data by use of the fully con-
ditional specification algorithm (non-monotonous data) [30,31]. The variables referral 
wish and referral by the research team were not imputed because of the small N for 
these variables and many possible outcomes: imputations were perceived as unrelia-
ble.
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Descriptive statistics were calculated for socio-demographic and illness-related charac-
teristics, the DT/PL, and health care use. Continuing elevated distress was defined as a 
DT score of ≥5 at both T1 and T2. Continuing low distress was assumed when patients 
reported a DT score of <5 at both timepoints. Survivors who developed recurrent/me-
tastasized breast cancer or another malignancy during the study period were excluded 
at T2.
Associations between DT/PL scores and changes herein over time (ΔT1 – T2) and 
time since diagnosis and time since chemotherapy were calculated by Spearman’s 
correlations to explore the effect of time on DT/PL responses. Chi-square tests and 
Mann-Whitney U tests were performed to explore univariate effects of socio-demo-
graphic and illness-related characteristics, health care use (dichotomized (Yes/No), 
problem domains and problem items at T1 on continuing elevated distress (patients 
with a DT score of ≥5 at both T1 and T2 versus patients with a DT score of ≤4 at one or 
both time points). Effect sizes (ES) were reported for significant results to examine the 
clinical relevance (Cramers’s V (V) for chi-square tests; r for Mann-Whitney U tests). An 
ES of 0.1 indicates a small effect, 0.3 a medium effect and 0.5 a large effect [32, 33]. 
Statistical analyses were performed using SPSS, version 24 (SPSS Inc. Chicago, IL).
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Seventy-seven of the 91 eligible survivors approached during the 1.5 year of the study 
at the UMCG, agreed to participate in the study (response=84.6%; Figure 1). The main 
reasons for survivors to decline study participation were a lack of interest to talk 
about their current psychosocial health status (N=7) or they did not feel comforta-
ble discussing psychosocial issues (N=3). Chemotherapy completion varied between 
1.0-4.8 years at study entry, and patients were on average three years after diagnosis 
(range=1.6-5.2). Fifty-four (74%) patients were receiving hormonal treatment at T1; 44 
at T2 (60%, Table 1).
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91 patients approached to 
participate 
77 returned questionnaires 
and informed consent 
These patients were all 
interviewed 
74 questionnaires were 
sent to eligible patients one 
year later 
3 excluded from study because 
of development of metastatic 
disease 
- 1 declined further   
   participation 
- 1 refused the interview at T2 
73 returned questionnaires  
72 completed interviews 
 
Figure 1. Flow chart of the study
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Table 1. Patient characteristics at T1 and univariate associations with continuing elevated distress 
(N=73).
Characteristic Median (IQR) N (%) Test statisticab (p)




























Time since diagnosis (years) 2.8 (2.1-3.7) U=336.2 (.040)
Time since chemotherapy completion 
(years)









 Chemotherapy and immunotherapy
 Chemotherapy and hormonal therapy






































Characteristic Median (IQR) N (%) Test statisticab (p)



















a = Average test result across imputed datasets
b = Continuing elevated distress was defined as a DT score of ≥5 at both T1 and T2.
U=Mann-Whitney U test; X2=Chi-square; IQR=Interquartile range
 
Distress and underlying problems
At T1, 35 survivors (48%) indicated they experienced clinically elevated distress. Twen-
ty-three (32%) reported elevated distress at T2. Eighteen survivors (25%) suffered from 
clinically elevated levels of distress both at T1 and one year later. Thirty-three (46%) re-
ported low distress at both timepoints (Table 2). The top five most often reported prob-
lems were in the physical and emotional domains (Table 3). Fatigue and lack of physical 
fitness were most often reported at T1 and T2, both by the complete sample and by 
survivors experiencing continuing elevated distress. Problems were more prevalent in 
the continuing elevated distress subgroup (e.g. fatigue: N=16/18; 89% (T1)) compared 
to the complete sample (fatigue: N=48/73; 66% (T1)). The number of survivors who 
reported one of the top five problems decreased from T1 to T2. At T2, more survivors 
with continuing elevated distress reported tension/nervousness and fears than at T1.
Variables associated with continuing elevated distress vs. no continuing 
elevated distress
Time since diagnosis and time since chemotherapy were not related to DT/PL scores 
at T1 or T2 and DT/PL change scores over time. Shorter time since diagnosis was sig-
nificantly related to a higher likelihood of reporting clinically elevated distress at both 
measurement points i.e. to experience continuing elevated distress (Table 1; r=0.24; 
small to medium ES). Also, survivors who accessed health care services between di-
agnosis and T1 (V=0.34; medium ES) and/or between T1 and T2 (V=0.28; small to me-
dium ES) were more likely to report continuing elevated distress (Table 1). Survivors 
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who had a higher score on the practical (V=0.38; medium to large ES), social (V=0.23; 
small to medium ES), emotional (V=0.33; medium ES) and/or physical (V=0.47; large ES) 
problem domains at T1 were more likely to indicate that they experienced continuing 
elevated distress (Table 2).
Table 2. Descriptives of the DT/PL scores at study entry (T1) and 1 year later (T2), changes over 
time and univariate associations between the problem domains and continuing elevated distress.
T1 T2 Continuing 
elevated distress
N (%) Median (IQR) N (%) Median (IQR) Test statistic (p)a
DT  4.0 (1.5-6.0)  3.0 (1.0-5.0)
 N scoring ≥5 35 (48) 23 (32)
Elevated distress at T1 and T2 18 (25)
Low distress at T1 and 
elevated distress at T2
5 (7)
Elevated distress at T1 and
low distress at T2
17 (23)
Low distress at T1 and T2 33 (45)
PL subscales
Practical (0-70)r  4.0 (0.0-11.5)  0.0 (0.0-8.0) U=255.4 (.002)
Social (0-30)r 0.0 (0.0-5.0)  0.0 (0.0-1.7) U=371.7 (.050)
Emotional (0-100)r  12.0 (3.0-35.0)  9.1 (0.0-22.0) U=279.7 (.005)
Spiritual (0-20)r  0.0 (0.0-0.0)  0.0 (0.0-0.1) U=440.1 (.297)
Physical (0-250)r 9.5 (9.5-46.5)  7.5 (15.4-34.0) U=181.4 (.000)
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Referral wish, health care use and actual referral to specific services
Table 4 displays survivors’ health care use, referral wish, actual referral at T1 and T2, 
and uptake of T1 referrals. At T1, 27 survivors considered (37%) and eight (11%) had 
a referral wish to a psychosocial and/or paramedical health care provider (Table 2). Of 
these last, two indicated they recently started receiving care for their needs. At T2, 12 
considered (17%), and 11 wished (16%) a referral. Two of the eleven had recently been 
referred (Table 4).
Between diagnosis and T1, supportive care was most often received from a psy-
chologist (N=27; 37%) or a physical therapist/lymphedema therapist (N=18; 25%). The 
most frequently visited health care providers between T1 and T2 were the physical/
lymphedema therapist (N=25; 34%)) and the psychologist (N=10; 14%). At T1, ten sur-
vivors (14%) were referred by the research nurse/psychologist after discussion of DT/
PL responses, most (N=6) to a psychologist. At T2, 11 (16%) survivors indicated having 
a referral wish and six (8% of the total group) were referred after discussion of DT/PL 
responses, three to a gynecologist/sexuologist and three to a psychologist. The one 
survivor who had been referred to a multidimensional rehabilitation program at T1 ac-
tually participated in the program. Of the six survivors referred to a psychologist, three 
actually went. The two survivors referred to a social worker and the one referred to a 
gynecologist/sexologist did not uptake the care service.
4
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This study was the first that longitudinally assessed the DT/PL in breast cancer survivors 
who were 1 to 5 years after chemotherapy completion and 19 months to 5 years after 
diagnosis. The findings of the present study are that at least one-third of long-term sur-
vivors experienced clinically elevated distress at one of the time points, and one in four 
survivors reported clinically elevated distress at both time points. This proportion lies 
well above estimates of psychological morbidity in the general Dutch female popula-
tion (between 10% and 19%; [34]). The percentage of patients with continuing elevated 
distress was somewhat higher than the 21% that was reported in a recent Dutch study 
that used the Dutch DT/PL and included survivors who were 15 months post-diagnosis 
[17]. This difference may be explained by the treatment modalities survivors received: 
63% of survivors in the aforementioned study received radiotherapy only whereas 
all survivors in the current study received chemotherapy. Patients who (also) receive 
chemotherapy in contrast to patients who receive other treatment modalities, report 
higher levels of distress [29,35] and lower emotional functioning at least up to 2 years 
after diagnosis [36]. The current study shows that a substantial proportion of breast 
cancer survivors experience clinically elevated levels of distress, even beyond the first 
year after chemotherapy completion.
Fatigue and lack of physical fitness were the most often reported problems as was 
reported previously [17,28]. Also, the finding that emotional problems such as tension/
nervousness and fears were frequently reported was in line with previous research. 
However, the prevalence of these problems was high compared to previous studies 
[17,28], especially for emotional problems: other studies with the DT/PL reported 
percentages of 40% or lower [17,28]. This may again be explained by the fact that all 
survivors in the current study received chemotherapy. Also, the women in our study 
were somewhat younger (Mean=50.6; median=52.1) compared to the other studies 
(Mean=57 [28]; Median=58 [17]) which may explain the higher distress levels [9]. The 
number of survivors who reported physical and emotional problems decreased over 
the one-year period but the numbers remained substantial. Also, a higher score for 
these problems at study inclusion, especially physical problems, increased the likeli-
hood that survivors reported continuing elevated distress. Thus, problems which un-
derlie distress can endure for years after chemotherapy completion in breast cancer 
survivors. Attention of health care professionals to lingering problems remains impor-
tant, even years after chemotherapy as these problems and distress may not resolve 
without additional support.
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Our findings show that a large proportion of survivors was or had been using sup-
portive health care services. Notably, the use of a physical/lymphedema therapist in-
creased from 25% to 36% over time. First symptoms of arm lymphedema may occur up 
to three years after surgery [37,38] and can explain the increase in use of this service. 
Also, specific problems such as a lack of physical fitness and a lack of muscle strength, 
which are highly prevalent among survivors in the current study, may have encouraged 
survivors to seek help from a physical therapist. More than a third of survivors indicat-
ed they had received care from a psychologist before they participated in the study. A 
study including all types of German cancer patients reported that approximately 30% 
had used psychotherapy and/or psychological counseling since they got cancer. The 
authors showed that women and patients with symptoms of depression and anxiety 
were more likely to use these services [39].
The referral wishes survivors reported and consequent referral made by a member 
of the research team after discussion of the DT/PL did not always align. This could in 
part be explained by the fact that some survivors recently started receiving care for 
their needs through self-referral. More importantly, the discussion of DT/PL responses 
helped survivors to elucidate which problems were most troubling and what type of 
support was (mostly) needed. Consequently, the wish to be referred to a professional 
of a certain discipline changed. This result underlines the importance of discussing DT/
PL responses as is being recommended in the Dutch guideline on distress management 
[20].
Our study had a number of limitations. The first is the small sample size. Therefore, 
we performed univariate analyses to explore associates of continuing elevated distress. 
Larger samples in future studies are needed to confirm and extend the current results. 
Second, a large variation existed between the time of chemotherapy completion and 
the first measurement (between 1-5 years after completion). However, the survivors 
seem to be a relatively homogeneous group considering the problems and health care 
use that were reported at both time points. Future research measuring survivors at 
fixed time-points during the illness trajectory can more precisely indicate survivors’ dis-
tress, problems, and health care use at specific time-points after chemotherapy com-
pletion. Finally, due to our study design, we were not able to assess whether survivors 
identified with continuing elevated distress experienced these levels of distress during 
the entire 1-year study period or at the measurement points only nor whether they 
suffered from elevated distress (at any time) during chemotherapy treatment.
Several important strengths can be noted. The current study was the first to lon-
gitudinally examine DT/PL responses in longer-term (breast) cancer survivors, particu-
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larly in those who were treated with chemotherapy as they often experience more 
problems than survivors who received other treatment types [9]. Second, we explored 
what problem domains were related to continuing elevated distress. One previous 
study related problem domains to distress but had a cross-sectional design and was 
performed in lung cancer patients [40]. Third, to the best of our knowledge, this is the 
first study that made an attempt to explore referral wish as measured with the DT/PL in 
combination with actual referral and uptake.
Considering the substantial proportion of longer-term breast cancer survivors who 
report (continuing) elevated distress, distress-related problems and referral wishes, 
distress screening and management remain important in clinical practice even years 
after completion of chemotherapy. Physical problems, especially fatigue and lack of 
physical fitness, were most prevalent and were most strongly related to reporting con-
tinuing elevated distress. We recommend to pay special attention to survivors experi-
encing these problems i.e. to discuss the impact of these problems on survivors’ lives, 
to inform survivors about the potential health risk of not treating these problems and 
to discuss possible (self-)management strategies for dealing with these distress-under-
lying problems.
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In this review the effect of internet-based support programs on psychosocial and phys-
ical symptoms resulting from cancer diagnosis and treatment is analyzed. Selection of 
studies was based on the following criteria: (non-)randomized controlled trials, per-
formed in adult cancer patients, comparing quantitative psychosocial and/or physical 
outcomes of an internet-based support program with (a) comparison group(s). Litera-
ture search yielded 2032 studies of which 16 fulfilled the eligibility criteria.
Three different internet-based support programs were identified: social support 
groups, online therapy for psychosocial/physical symptoms and online systems inte-
grating information, support and coaching services. Outcomes improved by these pro-
grams in nine studies. Especially fatigue, social support and distress improved, regard-
less of the program type. All online systems showed positive effects, mainly for social 
support and quality of life. This analysis indicates that internet-based support programs 
are effective in improving psychosocial and physical symptoms in cancer patients.
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INTRODUCTION
A diagnosis of cancer often has a disruptive impact on a patient’s life. Cancer patients 
frequently experience psychosocial and/or physical distressing symptoms [1-3]. The im-
portance of supporting patients adequately regarding symptoms resulting from diagnosis 
and treatment has been widely recognized [4,5]. However, supportive care needs still go 
unnoticed frequently [6,7]. To detect and meet the needs of this rapidly expanding pa-
tient population, the health care system is urged to develop and employ (cost-) effective 
programs to educate and support patients.
The internet is a viable medium by which patients can be supported regarding psy-
chosocial and/or physical symptoms. Already in 2007, a Dutch cross-sectional survey on 
cancer-related internet use demonstrated that 60% of patients frequently used inter-
net by themselves and 9% via others [8], reflecting the high acceptance of internet as a 
support and information channel. It has important advantages given its wide availability 
and accessibility, cost-efficiency and ability to provide tailored information and support 
[8-13]. During the last years, many new eHealth technologies have been introduced in 
cancer patient care, such as internet-based support programs addressing psychosocial/
physical problems, internet-based communication and decision aids to promote shared 
decision making [14] and mobile applications providing survivorship care plans [15].
Internet-based support programs seem particularly well-suited to fulfill the unmet 
supportive care needs [4]. These programs have been linked to positive outcomes such 
as increased knowledge, perceived social support and improved health behaviors for 
people with chronic diseases [16]. Given the comparable nature of chronic diseases and 
cancer, these outcomes may also apply to cancer patients [17]. Additionally, several stud-
ies showed the feasibility and acceptability of internet-based support programs for both 
psychosocial and physical symptoms in these patients [4,18,19].
Despite these promising findings, the effects of internet-based support programs 
specifically designed for cancer patients are less clear. Reviews on the effects of inter-
net-based support programs are scarce in the field of oncology. This paucity is due to the 
heterogeneous nature of these programs as well as measured study outcomes which 
renders rigorous evaluation of the effects difficult. The available reviews are either rather 
broad, for example summarizing all types of internet-based support including non-pro-
fessional resources [20], or specifically focus on a single type of support program (e.g. 
online psychological therapy [4]) or tumor type [12]. Also, assessment of study quality 
has received limited attention. Therefore, the aim of this review was to analyze published 
clinical trials to assess the effects of internet-based support programs. More specifically, 
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it was examined whether these programs are capable of alleviating psychosocial and/
or physical symptoms resulting from cancer diagnosis and treatment. Additionally, the 
(methodological) quality of the included studies was evaluated.
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METHODS
Eligibility criteria for article selection
Articles were selected based on the following eligibility criteria.
Study design 
Eligible studies were randomized controlled trials (RCT) and non-randomized con-
trolled trials (CT), performed in adult cancer patients (≥18 years), comparing quantita-
tive psychosocial and/or physical outcomes of an internet-based support program with 
(a) comparison group(s). ‘Cancer patients’ were defined as individuals diagnosed with 
any solid cancer type, irrespective of disease stage, treatment phase, type of treatment 
and time since diagnosis. Studies in mixed populations were only included if data for 
cancer patients were reported separately. Studies must have reported original data. 
Letters to the editor, patient stories, posters, thesis, review studies and non-English 
records were excluded.
Internet-based support program
An internet-based support program was defined as any program that aimed to reha-
bilitate or support cancer patients regarding psychosocial and/or physical symptoms 
resulting from diagnosis and treatment. Programs that were not primarily designed to 
support/rehabilitate (e.g. treatment decision aids and health behavior change inter-
ventions) were beyond the scope of this review and excluded. Programs focusing exclu-
sively on education were only included if the education aimed to support/rehabilitate 
cancer patients. The internet-based support program should have been designed by (a) 
health care professional(s). Studies regarding social support groups were eligible if the 
groups were moderated by a health care professional. Studies that described programs 
without access to the internet (e.g. CD-rom or DVD) or to a website (e.g. therapy via 
e-mail) were excluded.
Outcomes
Quantitative psychosocial (e.g. distress, anxiety, depression, quality of life (QoL)) and 
physical variables (e.g. fatigue, insomnia, pain and sexual problems) were the out-
comes of interest.
Search strategy and selection method
The CINAHL, MEDLINE (PubMed) and PsychINFO databases were searched from in-
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ception without limitations. For each database, one review author screened the titles 
and abstract of the retrieved records. Studies that were identified as clearly nonrele-
vant were excluded at this stage. Studies that were considered as potentially relevant 
or as ambiguous regarding eligibility were accessed in full-text and evaluated by two 
authors independently. The last search was performed on 31-01-2014. The following 
search terms were used alone or in combination: neoplasm, cancer, carcinoma, oncol-
ogy, internet, web, online, eHealth, telemedicine, patient education, social support, 
psycho-education, rehabilitation, support group, support system, therapy, disease 
management (see Appendix 1 for the full search). The search terms were extensively 
tested against the output retrieved from initial hand searches. Additionally, reference 
lists from retrieved articles and relevant systematic reviews were scanned to identify 
other eligible studies.
Quality assessment
Each included study was assigned a level of evidence according to the Oxford Cen-
tre of Evidence Based Medicine [21]. That system distinguishes five levels of evidence 
ranging from 1 (systematic review of randomized trials; the highest level of evidence) 
to 5 (mechanism-based reasoning; the lowest level of evidence). Additionally, we as-
sessed the methodological quality of the included studies following a checklist used in 
a review regarding internet-based interventions in chronic diseases [17], which is an 
adapted version of the Cochrane Collaboration Back Review Group [22]. We changed 
the item ‘method of randomization explained’ into ‘randomized groups’ as we also 
included non-randomized CTs. The item on ‘assessor blinding’ was excluded since it 
is not feasible to blind the assessor in case of self-report measures. The quality score 
could range from 0 to 12 points. See Table 3 for the checklist and scoring procedures.
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RESULTS
The initial search yielded 2,032 articles and was reduced to 15 original articles (=15 
studies) after application of the eligibility criteria. One additional article was identified 
after examination of the references of included articles and relevant systematic reviews 
(see Figure 1).
                              




















   
 
 




2032 articles identified by 
database search: 
- 1038: MEDLINE 
(PubMed) 
-   746: CINAHL 
-   248: PsychINFO 
451 duplicates excluded 
1581 articles 
1419 ‘clearly not relevant’ articles excluded 
based on title and abstract   
 
162 articles 
140 articles excluded after reading full-text (N) 
based on: 
- No focus on cancer survivors (4) 
- No use of the internet or website (10) 
- Not designed to support/rehabilitate (5) 
- No outcomes reported (23) 
- Feasibility/developmental study (13) 
- Not designed/moderated by professional (17)  
- Unstructured use of the internet (2) 
- Review, letter to the editor, patient story,    
   thesis or book chapter (20) 
- No relevant outcomes reported (22) 
- No full-text available (24) 
 
22 articles 
7 articles considering single-arm studies 
excluded 
15 articles 
1 article included (extracted from references of 
included articles) 
16 articles remaining for analysis 
included 
 
Figure 1. Inclusion process for the literature analysis
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Description of selected included studies
Characteristics of the included studies are summarized in Table 1. All studies were pub-
lished in 2001 or later, with the majority (N=10) being published after 2010. Sample sizes 
ranged from 27 to 450 participants. All studies had a pre- and post-test design to meas-
ure outcome differences in the group(s). Twelve studies were RCTs. Three studies used 
several experimental [23] or control [10,24] groups, all other studies used a single exper-
imental and control group (e.g. wait-list control, control group receiving usual care). One 
study examined two different types of programs, i.e. an online therapy for psychosocial 
symptoms with or without additional use of a support group [25].
Description of participants
The 16 studies comprised 2620 patients. Eight studies focused exclusively on female 
breast cancer patients. Four studies contained patients with various tumor types [25-
28], of which breast cancer patients constituted 39-64%. The remaining studies were 
performed in patients with prostate [24,29], head and neck [30] and gynecologic cancer 
[31]. Nine studies included only women and two studies only men [24,29]. The overall 
median age of the patients was 52 years (range 42-67 years; two studies did not report on 
age). Seven studies analyzed cancer patients with all disease stages (stage I-IV), whereas 
four studies only included patients with locally or locally advanced cancer (stage I-III) 
[24,28,31,32]. Five studies did not specify patients’ disease stage [23,29,30,33,34]. Six 
studies included solely patients who had completed cancer treatment during their fol-
low-up [24-26,28,31,35], one study only included patients during treatment [27] and two 
studies patients in all treatment phases [30,34]. The remaining studies did not specify 
patients’ treatment phase.
Description of internet-based support programs
Table 2 shows the characteristics of the internet-based support programs. Three different 
types of programs could be distinguished: social support groups [29,31,33-35], online 
therapy for psychosocial/physical symptoms [24-26,32] and online systems integrating 
multiple services such as information, support, communication and coaching services 
[10,23,27,28,30,36,37]. All but one study [34], provided patient education within the 
program. The majority of the programs provided the opportunity to communicate with 
peers [10,23,25,27,29-37] and/or professionals [10,23,24,27,28,30,31,34-37]. Exercises 
such as cognitive-behavioral homework and coping-skills training were part of the pro-
gram in five studies [23-26,32]. Except for one internet-based support program [26], all 
programs were facilitated by a moderator. The moderator’s role varied and included fa-
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cilitating a discussion and/or introducing new topics in a support group [33,35], being 
the expert to ask questions [10,23,27,36,37] or having an active role in the intervention 
such as chatting, discussing and mailing with participants [24,27,30,31,34]. Two studies 
[28,29] did not describe the role of the moderator. The duration of the programs ranged 
from 6 weeks to 1 year.
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Outcomes of included studies
The used measurement instruments and corresponding outcomes of the studies are 
presented in Table 2. Psychosocial outcome measures, such as (health-related) QoL, 
depression, distress/stress and perceived social support were the most common used 
outcome measures. Some studies used validated as well as self-constructed or modi-
fied questionnaires [10,23,24,26,28,30,31,33,33,34,36,37].
Positive effects of the internet-based support programs on outcome measures 
and/or measurement points were reported in nine studies. Of these, seven studies 
used online systems, one a social support group and one online therapy. Two stud-
ies mentioned that the number of included patients was insufficient to detect sig-
nificant differences [25,31]. Patients in the experimental group experienced a bet-
ter QoL compared to those in the control group(s) in three studies examining online 
systems [10,28,30] whereas eight other studies did not report any differences in QoL 
[23,26,27,29,32,34,36,37]. Two studies found positive effects within the experimental 
group(s) over time and stable or decreased QoL in the control group, but did not report 
differences between groups [24,29]. Only one [33] out of seven studies measuring de-
pression found a significant positive effect in favor of the intervention group. A social 
support group for breast cancer patients resulted in less perceived (post-traumatic) 
stress [33] and an online system for breast and prostate cancer patients diminished 
global symptom distress [27]. Other studies using psychological [24,31,32] or sexual 
distress [31] as outcome measure did not show any effects. Of the six studies having 
social support as an outcome, three [10,36,37] examining the ‘CHESS’ program found a 
positive effect in favor of the intervention group. Programs focusing on cancer-related 
fatigue [28] and insomnia [26] showed a positive effect on fatigue.
Only three studies examined long term effects (>3 months post-intervention) 
[10,23,24] of which one had positive long term effects up till 9 months after the end of 
the intervention on QoL and social support [10].
Quality assessment of included studies
Using the adapted Cochrane list for internet-based interventions, the median total 
score for methodological quality was 6 (observed range 1-8). The level of evidence 
based on the Oxford Centre of Evidence Based Medicine together with the (methodo-
logical) quality of the included studies is summarized in Table 3.
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DISCUSSION
The most apparent result from this review is that the majority of the included stud-
ies reported positive effects on patient-reported psychosocial and physical symptoms, 
regardless of the used program type. This result differs from a similar review conduct-
ed in 2010 [20]. That review focused on empirical studies (N=24 including 37 articles) 
reporting outcomes of the use of online support/resources by adult cancer survivors. 
The authors concluded that use of online support/resources showed promising but in-
conclusive evidence for positive outcomes due to a lack of rigorous evaluations. In the 
current review rather strict criteria for the final inclusion for analysis of studies were 
used. For example, only (non-)randomized controlled trials focusing on professionally 
designed internet-based programs for cancer patients were included. As a result, only 
five studies included in the previous review met our inclusion criteria. Moreover, our 
review includes ten studies published since 2010, of which six reported positive out-
comes.
Comparable reviews analyzing studies conducted in patients with chronic diseases 
also showed positive effects of internet-based support programs. A recent systematic 
review included 17 studies examining online mental health interventions in patients 
with chronic gastrointestinal conditions. That review showed that these online inter-
ventions resulted in less somatic symptoms and an improved quality of life [38]. Anoth-
er systematic review in patients with various chronic diseases including diabetes, heart 
failure and COPD (N=18 RCTs) found beneficial effects of internet-based interventions 
on patient empowerment [17]. A Cochrane systematic review involving 24 RCTs includ-
ing in total 3739 patients with chronic diseases found a positive effect of online systems 
on perceived social support [16]. This finding is in line with our review that showed 
positive effects for all online systems, mainly for the outcome social support. Given 
these findings, online systems may well be a generic tool to support patients with var-
ious diseases, in different disease stages and treatment phases.
The supportive care needs of cancer patients may differ depending on their so-
cio-demographic and illness-related characteristics. For example, several studies re-
ported that supportive care needs vary by age [39-41]. Therefore, it has been recom-
mended that interventions fit the characteristics and needs of recruited patients [4]. In 
the current review, patients’ median age was relatively young (52 years) compared to 
the median age of cancer patients at diagnosis which is 66 years [42]. The majority of 
the studies included in this review focused on breast cancer patients. Whether inter-
net-based support programs should be adapted to age groups and/or tumor types to 
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optimize effectiveness is unclear. Happily, several ongoing trials will shed light on this 
aspect as studies are ongoing in patients with tumor types such as prostate cancer, 
lung cancer and neuroendocrine tumors (ClinicalTrials.gov Identifiers NCT01716702, 
NCT01012401, NCT01849523) [43].
Our methodological quality assessment showed that the included studies could have 
been improved on several aspects in order to obtain a higher quality level. For example, 
in 14 of the 16 studies, study completers were not compared with drop-outs. This com-
parison may provide valuable information regarding which patients benefit from the 
internet-based support programs. Twelve of the included studies were conducted in 
the US. Caution is warranted in generalizing these results to patients in other countries 
because of possible differences in health care systems and expectations of the role of 
health care professionals as noted by the aforementioned Cochrane review [16].
A few limitations could be noted regarding our review. The included studies made 
use of many different outcomes. This heterogeneity hampers firm conclusions regard-
ing effects on some less frequently studied outcomes. Also, some included studies had 
small sample sizes (e.g. [25,31]). The absence of significant effects might be caused by 
a lack of power instead of true ineffectiveness of the intervention.
Since cancer patients make widespread use of internet-based technologies, the 
challenge is to provide easy accessible tools that will be of benefit for the individual 
patient. Internet-based technologies appear at a much greater pace than research can 
keep up with. A way to resolve this challenge is to examine the efficacy of generic 
program components and/or underlying principles that are more timeless than the 
programs themselves as has been proposed previously [44]. Successful implementa-
tion into routine cancer care represents another challenge but is crucial to reach the 
full potential of internet-based support programs. A barrier for patients might be a lack 
of accessible internet-based support programs that match their supportive care needs 
and preferences. Patient preferences for internet-based support vary considerably as 
demonstrated by a recent study on use patterns of the online system ‘WebChoice’ [45]. 
It cannot be expected that a few accessible programs will cover the supportive care 
needs of all patients. We recommend that more effort should be put in the disclo-
sure of available web-based support programs and tools. For example, a portal website 
could be constructed which contains all available supportive care programs/tools in-
cluding apps, websites and social media for cancer patients. As such, patients are pro-
vided with a choice what type of supportive care programs/tools matches their need 
and preferences. Ultimately, patients will receive the supportive care they wish for and 
benefit from the wealth of tools and programs delivered through the internet.
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APPENDIX 1. FULL SEARCH DATABASES
MEDLINE (PubMed)
(((Neoplasms[MESH] OR Carcinoma[Mesh]) OR (cancer*[TIAB] OR neoplasm*[TIAB] 
OR carcinoma*[TIAB] OR oncology[TIAB])) AND ((Internet[Mesh] OR web*[TIAB] OR 
online*[TIAB] OR internet*[TIAB]) OR (e-health*[TIAB] OR eHealth*[TIAB]) OR (tele-
medicine[MESH:noexp])) AND ((“Patient Education as Topic”[Mesh]) OR (“Social 
Support”[Mesh]) OR (psychoeducat*[tiab]) OR (“rehabilitation”[MESH]) OR (support 
group*[tiab]) OR (support system*[tiab])))
CINAHL
(((MH “Neoplasms+”) OR (MH “Oncology+”) OR TI (“cancer*” OR “neoplasm*” OR “car-
cinoma*” OR “oncology”) OR AB (“cancer*” OR “neoplasm*” OR “carcinoma*” OR “on-
cology”)) AND ((MH Internet+ OR MH telehealth+) OR TI (“internet*” OR “web*” OR 
“online*” OR “e-health*” OR “eHealth*”) OR AB (“internet*” OR “web*” OR “online*” 
OR “e-health*” OR “eHealth*”)) AND ((MH “Patient education”) OR (MH “Support, psy-
chosocial”) OR (MH “Psychoeducation”) OR (MH “Rehabilitation, Cancer”) OR (TI “sup-
port group*”) OR (TI “support system*”) OR (AB “support group*”) OR (AB “support 
system*”)))
PsychINFO
(((DE “Neoplasms” ) OR (DE “Benign Neoplasms”) OR (DE “Breast Neoplasms”) OR 
(DE “Endocrine Neoplasms”) OR (DE “Nervous System Neoplasms”) OR (DE “Terminal 
Cancer”) OR TI (“cancer*” OR “neoplasm*” OR “carcinoma*” OR “oncology”) OR AB 
(“cancer*” OR “neoplasm*” OR “carcinoma*” OR “oncology”)) AND ((DE “Internet”) 
OR (DE “Telemedicine”) OR TI (“internet*” OR “web*” OR “online*” OR “e-health*” 
OR “eHealth*”) OR AB (“internet*” OR “web*” OR “online*” OR “e-health*” OR 
“eHealth*”)) AND ((DE “Client Education”) OR (DE “Support Groups”) OR (DE “Psycho-
education”) OR (DE “Online Therapy”) OR (DE “Disease Management”) OR (DE “Reha-
bilitation”) OR (DE “Cognitive Rehabilitation”) OR (DE “Neuropsychological Rehabilita-
tion”) OR (DE “Neurorehabilitation”) OR (DE “Occupational Therapy”) OR (DE “Physical 
Therapy”) OR (DE “Psychosocial Rehabilitation”) OR TI (“rehab*” OR “support system*” 
OR “support group*” OR “patient educat*”) OR AB (“rehab*” OR “support system*” OR 
“support group*” OR “patient educat*”)))
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Context: Many breast cancer patients have unmet informational and psychosocial needs 
after treatment completion. A psycho-educational intervention may be well-suited to 
support these patients.
Objectives: The purpose of this multicenter randomized controlled trial was to examine 
the effectiveness of a web-based tailored psycho-educational program (ENCOURAGE) 
for breast cancer patients which aims to empower patients to take control over 
prevailing problems.
Methods: Female breast cancer patients from two hospitals in the Netherlands who 
recently completed (neo-)adjuvant chemotherapy were randomly assigned to standard 
care or 12-week access to the ENCOURAGE program providing fully automated 
information, problem-solving strategies, resources and services for reported problems. 
At 6 and 12 weeks, patients completed self-report questions on optimism and control 
over the future (primary outcome), feelings of being informed and acceptance of 
the illness. At baseline and 12 weeks, distress and quality of life questionnaires were 
completed.
Results: 138 patients were included. Almost all patients (67/69) visited ENCOURAGE 
as requested. No differences between the control and the intervention group were 
observed for primary and secondary outcomes. An unplanned subgroup analysis showed 
that in clinically distressed patients (N=57 at baseline; 41%), use of the ENCOURAGE 
program increased optimism and control over the future at 12 weeks more than in 
patients in the control group (Cohen’s d=0.65).
Conclusions: Although the effectiveness was not demonstrated, a subgroup of women 
treated for breast cancer can probably be supported by the program. The results of 
the current study are a starting point for further development and use of the program.
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INTRODUCTION
The presence of psychosocial and physical symptoms after completion of breast cancer 
treatment is well-known [1-3]. Patients struggle with psychological issues as well as 
physical symptoms [4,5]. Many patients wish for information about symptoms/prob-
lems that may arise after treatment completion and about strategies how to cope with 
these problems [1,6]. However, interventions that focus on supporting breast cancer 
patients during the first year after primary treatment completion (i.e. re-entry phase) 
are scarce [7-9]. Psycho-education, which combines patient education with activities 
such as advice on self-management strategies and/or counseling [10,11], may be 
well-suited to support patients during the re-entry phase. The few psycho-educational 
interventions that focused on breast cancer patients in the re-entry phase - delivered in 
multi-sessions via group, face-to-face and/or video format - showed positive effects on 
outcomes such as anxiety, depression, fatigue and quality of life [12-14]. Benefits were 
also found for a brief 2-hour psycho-educational group session regarding knowledge 
and preparedness for the re-entry phase [8]. These interventions required involvement 
of (a) health care professional(s) and, therefore, were relatively labor intensive. Con-
sidering the growing number of breast cancer survivors, the internet has been viewed 
as a cost-effective medium to support patients [15]. New web-based programs emerge 
at a rapid pace [16], but only few web-based interventions for breast cancer patients in 
the re-entry phase are available at present.
Therefore, we developed the ENCOURAGE program. This is a web-based tailored 
psycho-educational program for breast cancer patients in the re-entry phase which 
aims to empower patients to take control over prevailing problems and to adjust to 
life after treatment. We adopted a problem-solving orientation in the development 
of ENCOURAGE. This orientation involves appraising problems as challenges, be op-
timistic about the solvability of problems and having a sense of personal control over 
the problems [17]. According to the theory of problem solving, when patients learn to 
identify and solve problems, their sense of control and confidence will increase and 
these changes will in turn enhance adjustment [18,19]. Additionally, research showed 
that the use of active approach-oriented coping strategies (e.g. emotional expression, 
seeking social support) is related to perceived control and enhances healthy adjust-
ment to cancer [20-24]. The possible solutions to a problem offered by ENCOURAGE 
emphasize the use of approach-oriented coping strategies.
A randomized prospective study was performed to measure the effects of the EN-
COURAGE program. We hypothesized that breast cancer patients who use the program 
6
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report a larger increase in optimism and feelings of control over the future than pa-
tients who receive standard care. Patients’ feelings of being informed, acceptance of 
the illness, distress and quality of life were also studied.
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METHODS
Patients
Patients were recruited at the outpatient clinics of Medical Oncology Departments 
between January 2013 and October 2014 in two hospitals in the North-Eastern part 
of the Netherlands: the Martini Hospital (MH, Groningen) and the University Medical 
Center Groningen (UMCG, Groningen). The study was approved by the medical ethical 
committee and was registered (ClinicalTrials.gov, Identifier NCT01834521). Informed 
consent was obtained from all included patients. Female breast cancer patients diag-
nosed with primary breast cancer who completed curative-intent primary treatment 
within the past 6 months (defined as surgery combined with any type of (neo)adjuvant 
chemotherapy) were eligible. Patients might still be receiving immunotherapy, hormo-
nal therapy and/or radiotherapy.
Other inclusion criteria were: ≥18 years of age, ability to comprehend Dutch read-
ing and writing, having access to the internet including an e-mail address (at home or 
via family/friends) and physically and cognitively able to participate. Patients were not 
eligible when they were diagnosed with recurrent and/or metastasized breast cancer.
Procedures
This was a prospective, randomized controlled, multi-center, parallel-group study. Pa-
tients who were identified as eligible received a study information letter, an informed 
consent form, the baseline questionnaire (T0), an address form, two general informa-
tion leaflets (‘Breast cancer’ and ‘Continuing life after cancer’ of the Dutch Cancer Soci-
ety) and a prepaid return envelope. Patients who did not return the documents within 
two weeks received a reminder call.
After receiving the returned documents, patients were randomized between stand-
ard care (control group) or access to the ENCOURAGE program (intervention group) by 
a data-manager of the UMCG. The patients were allocated with a computer-generated 
randomization list using blocked randomization to conceal the allocation sequence un-
til intervention assignment (allocation ratio 1:1; block size of 4; stratified per hospital). 
Patients were informed by phone by the research psychologist about the randomiza-
tion outcome. Blinding of patients or the research team was not applied.
Patients received questionnaires at 6 (T1) and 12 weeks (T2) by mail. If question-
naires were not returned after 1 week, patients received a reminder e-mail. Patients 
were contacted by telephone if they did not respond within 1 week after the reminder.
6
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Intervention and control condition
Key features of ENCOURAGE (http://lastmeter.medischeoncologiegroningen.nl; us-
ername: JPainSymptomManage; password: Symptom1; Appendix 1) were inspired on 
problem-solving therapy [17,18]: 1) Problem orientation and identification: an online 
version of the Dutch Distress Thermometer (DT) and accompanying 47-item Problem List 
(PL) covering practical, family/social, emotional, religious/spiritual and physical problems 
[25] was used to identify the problems patients experienced. After completion, patients 
immediately received online feedback about their distress score. The feedback identified 
three levels of distress severity (DT=0-4 for no or mild distress; DT=5-7 moderate distress 
and DT=8-10 severe distress [25]); 2) Subsequently, patients received fully automated 
tailored psycho-education for the reported problems. Psycho-educational material was 
written for 30 problems separately, from a re-entry specific viewpoint (Appendix 212). Psy-
cho-education comprised background information about problems (including normal-
ization), possible problem-solving strategies for coping, resources including hyperlinks 
to other websites and services (for self-referral). Completed DT/PL’s were automatically 
saved online to ensure access to the psycho-educational material any time later. All DT/
PLs that were (partly) completed by patients were registered for study purposes. Program 
content was fixed during the 12 weeks. Patients could contact the research psychologist 
(telephone/e-mail) to discuss any questions and/or roblems.
The content of the ENCOURAGE program was based on contemporary scientific liter-
ature and input from a multidisciplinary team of psychologists, oncology nurses, medical 
oncologists, a pastoral worker and a patient advocate. Breast cancer patients within 9 
months after chemotherapy completion from the UMCG (N=12) evaluated the content 
of the program positively in terms of usefulness (Cohen’s d=0.30), feeling informed (0.66) 
and increased optimism and control over the future (0.96) in a small single arm pilot 
study compared to patients >9 months after chemotherapy (N=7).
Patients assigned to the intervention group, had access to the program during 12 
subsequent weeks. An e-mail was sent to patients containing a leaflet that introduced 
the ENCOURAGE program together with log-in information. Patients were requested to 
visit the program and to complete the online DT/PL at least once during the first 7 days 
after receiving login information to ensure that all participants received some amount of 
psycho-educational material. The research psychologist contacted patients that had not 
accessed the program within the first week (a reminder mail was send, after 2 weeks they 
received a telephone call). No further use requests were imposed.
2  Appendix 2 can be found in appendix A in this thesis
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Standard care consisted of regular visits to a medical specialist (medical, surgical or radi-
ation oncologist and/or oncology nurse) every 3 or 4 months during the first follow-up 
year. Patients were referred to additional health care by their oncologist and/or oncology 
nurse in case of unmet needs and/or a referral wish.
Measures
At baseline (T0), patient characteristics, health care use, distress and quality of life were as-
sessed. At 6 (T1) and 12 weeks (T2) optimism and control over the future, feeling informed 
and acceptance of the illness, were measured. At 12 weeks (T2) patients’ health care use, 
distress and quality of life were re-assessed. At T2, the intervention group also received a 
questionnaire regarding website opinion and use (T2).
A self-report questionnaire was used to assess socio-demographic characteristics. 
Illness-related characteristics and treatment received were collected from patients’ medi-
cal records. The questionnaire also asked whether psychosocial and/or paramedical health 
care had been used before breast cancer diagnosis, after diagnosis and/or during study 
enrollment.
Increased optimism and control over the future’ (primary outcome) is an 8-item sub-
scale (Cronbach’s alpha=0.75 (T1); alpha=0.79 (T2)) of the ‘Constructs Empowering Out-
comes’ (CEO) questionnaire [26]. This questionnaire is developed and tested in various 
online support groups including breast cancer patients [27,28]. The subscales ‘feel better 
informed’ (4 items; alpha=0.94; alpha=0.94) and ‘improved acceptance of the illness’ (5 
items; alpha=0.92; alpha=0.94) were also measured. The questionnaire assesses retro-
spectively to what extent patients experience certain outcomes by their participation in 
an online support group. We changed ‘online support group’ into ‘website’ and ‘informa-
tion leaflets’ for the intervention and control group, respectively. All items began with the 
statement: ‘Through the use of the website/information leaflets…’. Patients could answer 
on a 5-point scale ranging from ‘completely disagree’ (1) to ‘completely agree’ (5). For each 
subscale a mean total score was calculated. Total scores were not calculated for the CEO 
questionnaire as the subscales measure heterogeneous constructs [27].
Distress was measured using the Dutch DT/PL [25,29]. The DT consists of a single item 
that asks patients to indicate the amount of distress experienced during the past week on 
an 11-point scale (0-10; no to extreme distress). On the 47-item PL, patients could indicate 
whether or not (yes/no) they experienced certain problems. Patients were asked to rate 
from 1-10 the amount of distress they experienced for each item in the PL they answered 
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Quality of Life (QoL) was measured using the EORTC QLQ-C30, version 3.0 [30] and the 
QLQ-BR23 [31]. Global health status/QoL and the functional scales of these questionnaires 
(physical, role, cognitive, emotional, social functioning and body image, sexual functioning, 
sexual enjoyment and future perspective) were included.
The Technology Acceptance Model (TAM) questionnaire [32] was used to assess pa-
tients’ opinion of the ENCOURAGE program. The subscales ‘perceived usefulness’ (3 items, 
alpha=0.94), ‘positive attitude’ (1 item) and ‘actual usage’ (1 item) were assessed. Items are 
rated on a 5-point Likert scale, ranging from ‘completely disagree’ (1) to ‘completely agree’ 
(5). At the end of the questionnaire, patients had the opportunity to comment on the pro-
gram in free text format.
Data analysis
The power analysis was performed on the difference for the mean subscale score of ‘in-
creased optimism and control over the future’ between the control and intervention group 
at 12 weeks (T2). We aimed to recruit 128 patients (64 in each group) to detect a medium 
effect size of 0.50 using a two-tailed test (β=0.80; α=0.05 (G*power [34])). Recruitment 
continued until 128 patients returned the T2 questionnaire.
The range of missing values was 0.0%-13.8% for all variables except for distress at T2. 
This variable had 24.6% missing values. Missing data patterns were examined and subse-
quently multiple imputed (20 imputations) by use of the fully conditional specification al-
gorithm [35,36]. The results of the complete case analyses were similar to the results of 
the imputed datasets (N=138). Therefore, we decided to report the results based on the 
analyses of the original data.
Descriptive statistics were calculated for socio-demographic and illness-related charac-
teristics, CEO scales, TAM scales, QoL, the DT/PL and health care use. Analyses were per-
formed according to the intention-to-treat principle. Separate ANCOVAs were performed to 
examine the effect of study group on the CEO scales and on changes in the DT/PL and QoL 
domains from baseline to T2. Differences between the study groups in patient characteris-
tics, health care use and/or baseline measures were included as covariates in the ANCOVA 
models. Separate ANCOVA analyses were performed for clinically distressed breast cancer 
patients. Patients were defined as clinically distressed with a baseline DT score ≥5 [25,37]. 
These subgroup analyses were unplanned and therefore, underpowered. If standardized 
residuals of the ANCOVA model were non-normally distributed, the outcome variable was 
dichotomized (stable/improved scores versus worsened scores) and analyzed by a logistic 
regression analysis. Effect sizes were calculated by Cohen’s d for independent groups (mean 
unadjusted difference between the study groups divided by the pooled standard devia-
tion). Statistical analyses were performed by SPSS (v23; SPSS Inc. Chicago, IL).
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RESULTS
Patient characteristics
Of the approached 207 patients, 139 were enrolled in the study between January 2013 
and October 2014. Figure 1 displays the CONSORT diagram. Patients not interested to 
participate most often reported that they were too busy or did not want to be con-
fronted with cancer-related information. Characteristics of the patients in the control 
and the intervention group are provided in Table 1. Less patients in the control group 
received immunotherapy during the study period than patients in the intervention 
group (χ2=4.0, P=.047). No differences between study completers and dropouts were 
observed for the baseline measures.
6
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N=41 baseline questionnaires 
(72%)
N=98 baseline questionnaires 
(65%)
N=16 non-responses:
-12 not willing to   
participate
- 4 not reached
N=52 non-responses:
-47 not willing to   
participate







- N=6 did not return  
T1 (on time) 











- N=4 did not return  
T1 (on time)















Figure 1. CONSORT diagram of patient flow from patient approach to analyses. UMCG: Univer-
sity Medical Center Groningen; MH: Martini Hospital
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Table 1. Patient characteristics at baseline (N=138).
C I
N M ± SD N M ± SD P
Age (years) 69 53.2 ± 8.5 69 53.1 ± 9.8 .920
Time since diagnosis
(months)
69  8.7 ± 1.9 69  8.7 ± 2.1 .920
Time since chemotherapy
(months)
69  2.4 ± 1.7 69  1.9 ± 1.5 .078
C I














































































































































































































M=mean; SD=standard deviation; I=intervention group; C=control group; ns=non-significant
Indepent-samples t-tests (continuous variables) and Χ2 tests (categorical variables) were used to examine 
differences between study groups. 
Use and evaluation of the ENCOURAGE program
According to the log files, two patients never visited the program. One of these patients 
returned the questionnaires and the intention-to-treat principle was applied. Eighteen 
patients did not log in within 1 week and were reminded by e-mail. Seven patients re-
ceived an additional phone call as they had not logged in after 2 weeks. These contacts 
focused on program access and support was only provided for technical issues. The 
number of online DT/PLs patients started, ranged from 0-7 (median=2; N=69), with 
61% of the patients logging in more than once. Self-reported use of the program was 
similar to this usage statistic (range 0-6; median=2; N=62).
The mean score patients assigned to the usefulness of the program was 3.55 
(SD=0.89; N=59). Of the patients, 71% agreed (score=4) or completely agreed (score=5) 
with having a positive attitude towards the program. Ten percent was not satisfied with 
the program.
Three patients contacted the research psychologist to discuss problems and/or 
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health care needs. The number of problems reported on the online DT/PLs ranged from 
0 to 30 (M=14; SD=6). Psycho-education was provided most often (89x) for ‘lack of 
physical fitness’ (73% of total number of completed PLs)), ‘fatigue’ (71%), ‘problems 
with appearance’ (56%), ‘tingling in hands/feet’ (55%) and ‘lack of muscle strength’ 
(55%).
Primary and secondary outcomes
No significant difference was detected in ‘increased optimism and control over the 
future’ at T2 between the control and the intervention group. Also, no effects were 
detected for the primary outcome at T1. Patients in the control group reported high-
er scores for ‘being better informed’ and ‘increased acceptance’ than patients in the 
intervention group at T1. At T2, no differences between the study groups for these 
outcomes were obtained (Table 2). Both study groups improved equally well between 
T1 and T2 regarding ‘increased optimism and control over the future’, ‘being better 
informed’, and ‘increased acceptance’. Improvements in distress, distress-related prob-
lems and QoL were observed in both study groups but no significant differences were 
observed between the groups at T2 (Table 3).
Distressed breast cancer patients
Several patients reported that they did not felt supported by the ENCOURAGE program 
since they did not experience high distress for which they needed additional support. 
Therefore, we decided to analyze the 57 (41%) clinically distressed patients separately 
(N=21 in the intervention group, N=26 patients in the control group, N=10 missing data 
at T2).
Usefulness of the program was rated with a 3.75 (SD=0.75; N=21). Seventeen of 21 
distressed patients (81%) randomized in the intervention group agreed or completely 
agreed with having a positive attitude towards the program. More distressed patients 
in the intervention group (15%) than in the control group (38%) received radiotherapy 
during the study period (χ2=3.15, p=0.076, N=47).
The clinically distressed patients in the intervention group reported a higher in-
crease in optimism and control over the future at T2 than the patients in the con-
trol group (Table 2). Additionally, in the intervention group (M
change
=0.25), but not in 
the control group (M
change
=0.02), ‘increased optimism and control over the future’ im-
proved from T1 to T2 (95% CI=0.06-0.58, F(1,40)=6.31, P=.016, Cohen’s d=0.51). No 
between-group effects were observed for the secondary outcomes (Table 3).
6
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This study was among the first that evaluated the effects of a web-based tailored psy-
cho-educational intervention for breast cancer patients in the re-entry phase. Although 
results showed no harmful effects of the ENCOURAGE program, no additional benefi-
cial effects of the program compared to the information leaflets that are part of stand-
ard care, were observed. An explanation for the absence of effects may be that certain 
patients could not further increase in optimism and control over the future. For exam-
ple, patients who suffer from minor symptoms may not experience an increase herein 
after use of the program as they feel that their symptoms are already in control. Thus, 
the program may be effective for a subgroup of patients only. This hypothesis may be 
reflected by our finding that the program increased feelings of optimism and control 
over the future more than standard care in the subgroup of patients with clinically el-
evated distress at baseline. This might imply that distressed patients benefit from such 
a web-based program. About 30-60% of breast cancer patients suffer from clinically 
elevated distress during the first 6 months after treatment completion [38]. Similarly, 
we found 41% of the breast cancer patients to be distressed at baseline of the study. If 
the program is of help to distressed patients, a relatively large patient population may 
benefit from the use of the ENCOURAGE program. However, this is a premature con-
clusion and the results of the subgroup analyses should be interpreted with caution as 
they were unplanned and underpowered.
Methodological considerations
The absence of findings may, in part, be explained by the design of the program and the 
intervention onset. Considering the rather low program use, patients may have been 
exposed too little to the content of the program to solicit any observable effect. The 
ENCOURAGE program adopted a problem-solving orientation. Problem solving therapy 
(PST) includes the elements: problem orientation, problem definition, generation of 
alternatives, decision-making, solution implementation and verification that should be 
stepwise addressed [18]. Our program incorporated problem orientation and problem 
definition but the other elements were only implicitly addressed in the psycho-ed-
ucational material. About 10 sessions are recommended to deliver an effective PST 
intervention [18,19]. During the 12-week access to the program, patients were not 
guided throughout all the PST phases, probably contributing to the absence of effects. 
Future research with the ENCOURAGE program should incorporate all PST phases with 
homework assignments to practice new skills. The adapted program should be tested 
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in distressed patients, immediately after completion of chemotherapy to ensure that 
survivors receive support at an early phase.
Positive adjustment questionnaires, like the CEO questionnaire, are scarce. This 
questionnaire suited the purposes of the current study: it was specially developed to 
assess outcomes by the use of web-based programs and was tested in breast cancer 
patients. However, as baseline scores could not be derived due to its retrospective 
nature and it is not extensively validated, it might lack sensitivity to measure change.
Several strengths can be noted. The current RCT evaluated a web-based psycho-ed-
ucational program that targets a gap in survivorship care wherein breast cancer patients 
report high unmet needs [1,6]. At present, very few of such programs are available. The 
study was conducted in line with the CONSORT statement for reporting eHealth inter-
ventions [39,40]. The included patients varied in socio-demographic and illness-related 
characteristics and distress reflecting the representativeness of the current sample.
 
CONCLUSION
In contrast to our expectations, no effects in favor of the ENCOURAGE program were 
observed. Given the findings that especially distressed patients evaluated the program 
positively, a subgroup of breast cancer patients might benefit from this intervention. 
We aim to further develop and test the program. The valuable information of the cur-
rent study can be used as a starting point for further improvement and use of the 
program.
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Appendix 1a. Screenshot of the ENCOURAGE program (Dutch): problem identification
Appendix 1b. Screenshot of the ENCOURAGE program (Dutch): psycho-educational material for 
the problem tension/nervousness (fragment)
6
538881-L-sub01-bw-Admiraal
Processed on: 13-12-2019 PDF page: 144
538881-L-sub01-bw-Admiraal
Processed on: 13-12-2019 PDF page: 145
CHAPTER 7
Summary and future perspectives
538881-L-sub01-bw-Admiraal




Processed on: 13-12-2019 PDF page: 147
147
Summary and future perspectives
SUMMARY AND FUTURE PERSPECTIVES
Patients confronted with a diagnosis of cancer face numerous challenges in the emo-
tional, social, practical, spiritual and/or physical life domains which may cause psycho-
social distress. Appropriate screening and adequate management of patients’ distress 
and underlying problems is of great importance in adjusting well to the cancer expe-
rience. Insight into the factors associated with high distress, underlying problems and 
into the factors related to having a referral wish can aid timely identification and ade-
quate management of patients’ distress and problems. However, knowledge is limited 
regarding these issues.
Web-based programs seem to have potential in supporting patients regarding (self-)
management of distress and problems. These programs emerge at a rapid pace [1] but 
relatively little is known about their effects on the outcomes of patients with cancer 
[2,3]. A stronger research base is needed to establish the value of these programs for 
clinical practice. 
The main aims of the current thesis were to: 1) increase insight into factors related 
to high distress, underlying problems and referral wish as measured with the Distress 
Thermometer (DT) and Problem List (PL) in patients with cancer (part 1) and to; 2) 
examine effects on patient reported-outcomes, of web-based programs that aim to 
alleviate psychosocial and physical symptoms (part 2). In this chapter, the results of 




Chapter 1 introduced the background, aims and outline of the thesis. The concept of 
distress was described as well as the Dutch guideline on distress management includ-
ing the Dutch DT/PL (see appendix A for the Dutch and English versions of the DT/PL). 
Also, current evidence regarding the effects of web-based support programs in patients 
with cancer was presented. 
Part 1 | Distress, underlying problems and referral wish in patients with cancer
In chapter 2 a first systematic attempt was made to identify optimal DT cutoff scores 
for patients with different cancer types. A DT cutoff score indicates the minimal score 
at which patients are perceived as clinically distressed. The aim of the study was to 
examine the hypothesis that distress levels and cutoff scores depend on cancer type 
7
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and/or treatment type. The effect of socio-demographic and illness-related variables 
on distress was also examined. A large heterogeneous sample of patients with cancer 
was included (N=1340) varying in socio-demographic and illness-related characteristics 
including cancer type and varying in distress. Prostate cancer patients reported expe-
riencing lower distress than patients with breast, digestive, lung, gynecologic, head/
neck and liver/brain/thyroid cancers. Also, a lower cutoff of ≥4 on the DT was found 
for prostate cancer patients than the cutoff of ≥5 for breast, digestive, gynecologic and 
head/neck cancer patients. Lower distress in prostate cancer patients seemed to be 
partly treatment-related. Two thirds of the prostate cancer patients were in watch-
ful waiting, or underwent surgery or radiotherapy only. These non-intensively treat-
ed prostate cancer patients reported lower distress than intensively treated prostate 
cancer patients, intensively treated non-prostate cancer patients and non-intensively 
treated non-prostate cancer patients. Besides having a non-prostate cancer type, high-
er distress was associated with receiving treatment that involved more than surgery 
only and being a younger woman. The DT cutoff scores determined in the current study 
(either ≥4 or ≥5 depending on cancer type and treatment intensity) can be used as a 
first screen in screening for clinically elevated distress. As the rule-in ability of the DT is 
more limited, the identified risk factors i.e. having a non-prostate cancer type, receiv-
ing treatment other than surgery only and being a younger woman, may assist in the 
identification of patients at risk of developing clinically elevated distress. This informa-
tion can guide clinical decision making of whom to refer to professional psychosocial 
and/or paramedical health care.
The ultimate goal of distress screening is to refer patients to appropriate health 
care services, if needed or wished, for treatment of identified problems [4]. Howev-
er, no conclusive evidence is available on the factors that are related to referral wish. 
Therefore, in chapter 3, we examined effects of cancer patients’ perceived distress and 
problems, socio-demographic and illness-related variables, and social support suffi-
ciency on referral wish. The same large heterogeneous sample was used (see chapter 
2). Thirteen percent of the patients requested a referral to psychosocial and/or para-
medical health care services, while 21% considered a referral. Independent effects of 
five variables were found, namely patients who experienced more distress, had more 
problems in the practical and/or emotional domain, patients who were under active 
treatment or recently diagnosed, and/or those who were younger were more likely to 
express a referral wish. Distress level and emotional and practical problems appeared 
to be more powerful predictors of referral wish than the socio-demographic, social and 
clinical characteristics. This has not been reported before and suggests that responses 
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on the DT/PL provide more information to health care professionals when deciding on 
whom to refer than just socio-demographic, social and clinical characteristics. Patients 
with a high distress score (DT≥5) were three times more likely to express a referral wish 
than patients with a low score (DT<5). However, not all with a distress score of ≥5 on 
the DT expressed a referral wish and some patients with low distress desired a referral. 
This was also reflected by the finding that variables predicting higher distress (chapter 
2) were not identical to the variables associated with a referral wish (chapter 3). For 
example, patients with prostate cancer reported lower levels of distress than patients 
with other types of cancer whereas the percentage of patients with prostate cancer 
expressing a referral wish was similar to that of patients with a non-prostate cancer 
type. These results suggest that screening for distress is helpful in identifying patients 
with a high symptom burden but is insufficient to determine who would desire or need 
additional care, even when used in combination with the risk variables identified in 
chapter 2. This underlines the importance of discussing DT/PL responses including dis-
tress level, distress-underlying problems and referral wish with all patients, regardless 
of their distress level.
In chapter 4, distress levels, underlying problems, referral wish and supportive 
health care use were examined in a cross-sectional group of breast cancer survivors 
at two-time points with a one-year time interval. The survivors had completed chemo-
therapy 1 to 5 years earlier. Also, socio-demographic and illness-related variables and 
underlying problems associated with continuing elevated distress were explored. Con-
tinuing elevated distress was defined as a distress (DT) score of ≥5, at both assessment 
points. At least one-third of the longer-term survivors experienced clinically elevated 
distress at one of the time points (DT≥5), and one in four survivors reported clinically 
elevated distress at both time points. A shorter time since diagnosis, more health care 
use, and a higher level of practical, social, emotional and physical problems were sig-
nificantly associated with continuing elevated distress. Physical problems were most 
strongly related to continuing elevated distress. Fatigue and lack of physical fitness 
were most frequently reported by survivors in this setting. A large proportion of survi-
vors was or had been using supportive health care services, mostly from a psychologist 
and/or a physical or lymphedema therapist. Eleven percent of the survivors wished a 
referral and 37% considered a referral. At the assessment one year later, 16% wished 
and 17% considered a referral. These results indicate that screening and management 
of distress, problems and referral wish are important, even years after chemotherapy 
completion as a substantial proportion of breast cancer survivors continue to report 
elevated distress and problems. Special attention should be paid to survivors reporting 
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physical problems, especially fatigue and lack of physical fitness, since these problems 
seem to be most strongly related to continuing elevated distress.
Part 2 | Web–based support programs for patients with cancer
Many patients with cancer turn to the internet to search for cancer-related informa-
tion. Already in 2007, a Dutch cross-sectional survey on cancer-related internet use 
demonstrated that 60% of patients themselves frequently used the internet and 9% 
asked others to search for them [5]. Internet-based support programs seem particularly 
well-suited to fulfill unmet supportive care needs and can aid patients in self-managing 
psychosocial and physical symptoms experienced [6]. Generally, patients with cancer 
have a positive attitude towards self-management and web-based interventions. Pa-
tients are especially interested in web-based programs that provide support on how to 
handle and/or cope with the consequences of cancer [7]. The second part of this thesis 
examined the effects of web-based support programs on patient reported outcomes. 
In order to increase the existing knowledge on the effects of web-based support pro-
grams, a systematic literature analysis was performed in chapter 5. More specifically, 
it was examined whether these programs alleviate psychosocial and/or physical symp-
toms resulting from cancer diagnosis and treatment. Database and citation searches 
resulted in the selection of 16 eligible studies. Results showed that the majority of the 
included studies (9 of 16 studies) reported positive effects, especially on fatigue, social 
support and distress. The review was the first to link effectiveness to program type. The 
effectiveness varied across program type. All web-based programs that integrated mul-
tiple services such as information, support, communication and/or coaching services 
reported at least one significant positive effect, mainly on social support and quality 
of life. Only one of the included studies on web-based social support groups in which 
patients share personal experiences, feelings and information regarding psychosocial 
and/or physical symptoms, reported a positive effect. This was also the case for stud-
ies on web-based therapy, in which face-to-face therapy for specific symptoms (e.g. 
sexual problems, depressive symptoms) was replaced by web-based communication. 
The methodological quality assessment in our review showed that many studies on 
web-based support programs need improvement regarding study design and/or re-
port of the study. Also, the included studies made use of many different outcomes. 
These methodological issues and heterogeneity hamper firm conclusions about the 
effectiveness of web-based programs on symptom management. In short, the results 
are promising but more studies are needed using rigorous study designs and standards 
in reporting before these programs will be integrated in routine cancer care.
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In chapter 6 a multicenter randomized controlled trial that was performed to exam-
ine the effects of the ENCOURAGE program is described. The ENCOURAGE program 
is a web-based tailored psycho-educational program for breast cancer patients in the 
re-entry phase (i.e. the first year after primary treatment completion) which aims to 
empower patients to take control over prevailing problems and to adjust to life after 
treatment. Several self-reported outcomes were assessed to test the effect of the pro-
gram including the primary outcome ‘optimism and feelings of control over the future’. 
Of the patients, 71% (completely) agreed with having a positive attitude towards the 
program. In contrast to our expectations, no effects in favor of the ENCOURAGE pro-
gram were observed compared to the information leaflets that are standardly given 
to all patients. However, the program showed a positive effect on the primary out-
come in distressed patients (DT score ≥5) in the intervention group compared to dis-
tressed patients in the control group. The effect size was medium to large (Cohen’s 
d=0.65) indicating a relevant difference.  Also, 81% of distressed patients (completely) 
agreed with having a positive attitude towards the program. Thus, the program may 
be effective for distressed patients only but this hypothesis needs further testing as 
the subgroup analyses were underpowered. The absence of findings for the complete 
group may also be explained by the design of the program and the intervention onset. 
The ENCOURAGE program adopted a problem-solving orientation: some elements of 
the problem solving therapy (PST) were only implicitly addressed in the psycho-edu-
cational material. Thus, during the 12-week access to the program, patients were not 
guided throughout all the PST phases, possibly contributing to the absence of effects. 
Future research with the ENCOURAGE program should incorporate all PST phases with 
homework assignments to practice new skills. The adapted program should be tested 
in distressed patients, immediately after completion of chemotherapy to ensure that 
survivors receive support at an early phase. Concluding, the results of the ENCOURAGE 
study are promising as distressed patients evaluated ENCOURAGE positively and seem 
to benefit from the intervention. The issues raised regarding patient selection and use 
of an intervention which is firmly based on a theoretical model, can be used as a start-
ing point for further improvement and use of the program. 
7
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DISCUSSION AND FUTURE PERSPECTIVES
Part 1 | Distress, underlying problems and referral wish in patients with cancer
The value of distress screening in clinical practice
During the last years a strong case is being made to routinely screen for distress in 
oncologic practice as clinicians may overlook the need of supportive care [8]. A sub-
stantial number of patients report high distress but no referral wish and some patients 
with low distress desire a referral (chapter 3). The question may come to mind whether 
screening for distress and underlying problems should be discarded and replaced by 
a direct question to patients whether patients have a need for additional supportive 
health care [9,10]. It is important to ask patients about the presence of a referral wish 
as this may empower patients to make their own choices [11]. However, replacing 
the distress screening process by a simple help question would provide insufficient 
information. If distress level and referral wish do not align, this is valuable information 
which can guide the discussion of DT/PL responses. Chapter 3 provides an in-depth 
discussion of the possible reasons why patients with clinically elevated distress may 
not wish a referral. Motives to decline a referral vary substantially. Communication 
between a health care provider and a patient may uncover patient’s motive(s), possi-
bly leading to referral and uptake of professional care. Similarly, patients with overall 
low distress may desire a referral to manage a problem they experience. Discussion of 
the DT/PL response with patients who report low distress can provide important in-
sight into the severity of separate problems and can guide subsequent referral practice. 
Thus, optimally supporting patients will be achieved best by screening and discussing 
distress level, distress-underlying problems and referral wish.
Future directions for distress screening research
As the psychometric properties of the DT/PL and the effectiveness of distress screening 
become increasingly established [12,13], a shift in research focus is required. During 
the last years, considerable progress has been made in integrating distress screening 
into routine cancer care, worldwide and in the Netherlands [14]. Still many organiza-
tions do not use a distress screening program. As implementation of a distress screen-
ing program requires more than simply use of a screening tool, organizations that wish 
to implement such programs are faced with several practical implementation issues 
[15]. Criteria that can aid in implementation of a distress screening program have been 
defined, such as appointing a project manager and setting goals which are frequently 
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evaluated, but evidence based on rigorous studies is lacking [4]. Also, barriers and facil-
itators for successful implementation require further investigation. 
Acceptability of the screening procedure to patients has been perceived as a key 
factor in successful implementation [13,16]. A recent article found that patients who 
received information about the purpose of the screening procedure and the DT/PL and 
who were informed about availability and expertise of allied/psychosocial care pro-
fessionals, expressed a more favorable opinion regarding screening and DT/PL com-
pletion. Also, patients appreciated discussion of DT/PL responses with a health care 
professional and this was related to recommending the screening procedure to others 
[17]. Future research may identify additional factors that are related to the accepta-
bility and effectiveness of different screening procedures and may examine whether 
preferences vary across patients.
Acceptability of the procedure to health care professionals’ is a second factor. 
Health care professionals may perceive that screening takes valuable time from their 
regular tasks [15]. Research indicated that this concern is unfounded. In fact, time is 
used more efficiently as only problems that are reported by the patient are discussed 
[4,18,19]. Acceptability can be enhanced by informing health care professionals about 
efficient use of time. Health care professionals may also be reluctant about screening 
as their screening and communication skills are limited. Targeted training can improve 
these skills [20]. An important aspect herein is training regarding referral pathways and 
communicating with patients about a referral. Screening showed to be more effective 
when linked to triage, predetermined pathways for referral, and/or an intervention 
[21-23]. Future research may focus on the content and extensiveness of such referral 
instructions health care professionals need to optimally support patients. 
Due to screening, more patients may be referred to additional health care. As a 
consequence, costs of health care use may increase. Stepped-care may be a useful ap-
proach as it is regarded as efficient in terms of costs and use of resources. Stepped-care 
provides patients in need with a least resource-intensive treatment but is followed, 
if necessary, by more resource-intensive treatments [24]. A low-resource intensive 
intervention is for example a web-based intervention or a guided self-help interven-
tion while use of a specialized psychosocial health care professional [e.g. psychologist, 
psychiatrist] is highly resource intensive. Recent studies showed that stepped-care im-
proved patients with cancer’ well-being [25] and referral practice [26]. The subsequent 
steps varied across studies and the question what steps are most effective can be the 
target of future research. Also, studies on the cost-effectiveness of the stepped-care 
approach are scarce and need further study [27].
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Part 2 | Web–based support programs for patients with cancer
Future research into the effects of web-based programs
As current research on web-based programs for patients with cancer is heterogeneous 
in terms of measured outcomes, quality and report of the studies, it is difficult to for-
mulate best-practice recommendations [28,29]. The use of standards to which stud-
ies should comply, can enhance the scientific value of research in this area. Special 
papers were published on the relevance of the Consolidated Standards of Reporting 
Trials (CONSORT) statement for eHealth2 research including an adapted checklist for re-
search in this area [31,32]. Applying these standards both improve reporting of eHealth 
research and may also serve as a guide for researchers in design of their interventions 
and studies [31]. Additionally, use of these standards can enhance homogeneity of the 
studies. 
As it is expected that routine care and the use of web-based interventions will be in-
creasingly intertwined in the future, the need for rigorous methods to evaluate eHealth 
interventions is of great importance [30,33]. Randomized controlled trials (RCTs) have 
been perceived as the ‘gold standard’ in examining the efficacy of therapeutic interven-
tions but may have some disadvantages with respect to eHealth interventions research 
[1,34]. For example, randomizing patients between a control and intervention condition 
may be unethical when it is strongly expected that the web-based intervention is supe-
rior to the control condition i.e. violation of the equipoise principle [34,35]. A stepped 
wedge cluster design may be a solution to this problem. In this design, clusters, for 
example hospitals, are randomly allocated to the intervention or the control condition. 
Initially, all clusters are in the control condition. The intervention is being implemented 
sequentially. Eventually, all clusters will be receiving the intervention[35, 36]. Another 
advantage of this design is that the intervention is evaluated during implementation in 
routine practice thus, speeding up the availability of the intervention [37]. This is im-
portant advantage as the classical RCT is time-consuming while eHealth interventions 
develop in a rapid pace. Another way to increase the efficiency of eHealth research is 
to conduct small sample studies that examine sub-questions regarding intervention 
effectiveness. Third, the use of factorial designs allows for simultaneous evaluation of 
multiple intervention components with no loss of power compared to a classical RCT in 
which only one intervention type/component can be examined [1].
2 “ ‘eHealth’ generally refers to the use of information technology, including the Internet, digital gaming, virtual reality, 
and robotics, in the promotion, prevention, treatment, and maintenance of health.”; as defined by Borelli & Ritterband, 
2015 (30).
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Finally, in eHealth effectiveness research, it is important to develop theoretical mod-
els that capture the mechanisms underlying an intervention [1,38,39]. At present, the 
large majority of the studies on web-based interventions make too little use a of a 
theoretical model in the development of the intervention and in the identification of 
outcome measures [39]. Mediation and moderation analyses are helpful in building 
these models. Mediation analyses provide insight in how interventions work i.e. these 
analyses can examine if the theory of the intervention is correct. Moderation analyses 
identify factors that enhance or decrease the effectiveness of an intervention. For ex-
ample, an intervention may be more effective for younger than for older patients with 
cancer and/or for certain cancer subpopulations. Such information is important as it 
aids in optimizing the intervention.
Clinical implications
The use of eHealth can be of great value in clinical practice given its cost-efficiency and 
wide accessibility. In the Netherlands, the popularity of eHealth increased during the 
last years. In 2014, mental health organizations reported that 50% of their patients will 
be treated using eHealth soon [40]. National mental health associations have adopted 
the implementation of eMental health as a key policy theme. A popular approach in 
mental health care is blended care: a combination of online and face-to-face therapy. 
It is expected that blended care combines the advantages of face-to-face and online 
treatment. Research into the safety, efficacy and efficiency of blended treatment has 
only recently begun [37]. Recent trials reported promising results [41,42], including for 
cancer patients [43] but these studies need replication in rigorous study designs. Also, 
a rationale for the development of blended care is often lacking and general principles 
i.e. what type of ‘blend’ works for whom, and why is unclear at present [44]. Thus, 
while eHealth can enrich health care, it is important that implemented web-based in-
terventions are based on evidence. As suggested in the previous paragraph, scientific 
evaluation of these interventions can both be rigorous and fast.
Another challenge is the availability of eHealth interventions. Patient preferences 
with respect to eHealth vary considerably [45]. It cannot be expected that a few acces-
sible interventions will cover the supportive care needs of all patients. We recommend 
that more effort should be put in the disclosure of available evidence-based eHealth 
interventions. For example, a portal website could be constructed which contains all 
available eHealth interventions including websites, apps and social media for patients 
with cancer. As such, patients can choose what type of intervention matches their 
needs and preferences. 
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Appropriate screening and adequate management of patients’ distress and underlying 
problems is of great importance in adjusting well to the cancer experience. The current 
thesis showed different approaches by which patients can be supported in dealing with 
distress and problems. Distress screening is a key aspect in the support of patients. 
Knowledge of factors related to high distress, underlying problems and referral wish 
(which was identified), can aid in the optimal use of the DT/PL by health care profes-
sionals and hence, in adequately referring patients who are in need of additional sup-
port for their problems. The current thesis also showed that web-based support pro-
grams are feasible and can be effective in alleviating patients’ problems. In the coming 
years, it is expected that the evidence for the efficacy of web-based interventions will 
further accumulate. Thus, both screening and web-based programs can be of valuable 
addition to traditional practices in cancer care. Hopefully, these approaches will soon 
be fully integrated in routine cancer care worldwide. 
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De diagnose ‘kanker’ en de daaropvolgende behandeling(en) hebben ingrijpende 
gevolgen voor de patiënt en zijn/haar naasten. Als gevolg hiervan kunnen problemen 
ontstaan op lichamelijk gebied maar ook op emotioneel, sociaal, praktisch en/of lev-
ensbeschouwelijk/spiritueel gebied. Het totaal van deze problemen wordt aangeduid 
met de term ‘distress’ (‘last’). Psychosociale signalering - het proces van het detecteren 
van de aard en ernst van problemen van patiënten, communicatie over deze proble-
men en eventuele doorverwijzing - is belangrijk om distress op het spoor te komen en 
om als zorgverlener de patiënt hierin adequaat te kunnen ondersteunen. Inzicht in de 
factoren die samenhangen met het ervaren van veel distress, met onderliggende prob-
lemen en met het hebben van een verwijswens kan bijdragen aan het tijdig herkennen 
van patiënten met veel distress en problemen, en vroegtijdige doorverwijzing naar een 
psychosociale en/of paramedische zorgverlener realiseren.
Online interventies worden in toenemende mate gebruikt in de gezondheidszorg. 
Ook voor patiënten met kanker komen steeds meer online programma’s beschikbaar. 
Sommige van deze programma’s ondersteunen patiënten in het omgaan met psycho-
sociale en/of lichamelijke klachten die het gevolg zijn van de ziekte en de behande-
ling(en). De wetenschappelijke onderbouwing van deze (zelf)hulpprogramma’s is ech-
ter nog mager. Meer bewijsvoering is dus noodzakelijk om de waarde hiervan voor 
patiënten met kanker te kunnen vaststellen.
Het doel van dit proefschrift was tweeledig: 1) om inzicht te verkrijgen in de factoren 
die samenhangen met het ervaren van veel distress en problemen en in het hebben 
van een verwijswens naar psychosociale en/of paramedische zorg bij patiënten met 
kanker; 2) onderzoeken wat de effecten op patiënt-gerapporteerde uitkomsten zijn van 
online (zelf)hulpprogramma’s die als doel hebben om patiënten te ondersteunen in het 
omgaan met psychosociale en/of lichamelijke problemen.
In hoofdstuk 1 zijn de achtergrond, de doelen, en de opbouw van het proefschrift bes-
chreven. Het concept distress wordt besproken evenals de Nederlandse richtlijn ‘De-
tecteren behoefte psychosociale zorg’. Tevens wordt de ‘Distress Thermometer and 
Problem List’ (DT/PL) geïntroduceerd, in het Nederlands de ‘Lastmeter’ genoemd (zie 
appendix A voor de Engelse en de Nederlandse versie). De Lastmeter is een vragenlijst 
voor patiënten waarmee de zorgverlener zicht kan krijgen op de aard en ernst van de 
problemen die de patiënt ervaart (distress). Ook kan de patiënt op de Lastmeter aan-
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geven of hij/zij wenst om met een zorgverlener over de ervaren problemen te praten 
en eventueel, met wie hij/zij wil praten. 
In hoofdstuk 1 wordt tevens de huidige kennis uiteengezet over de effecten van 
online (zelf)hulpprogramma’s voor patiënten met kanker. Online programma’s die zich 
richten op het verlichten van psychosociale en/of lichamelijke problemen van patiënt-
en hebben in dit proefschrift de aandacht. De aanwezige kennislacunes met betrekking 
tot deze programma’s worden toegelicht.
Deel 1 | Distress, onderliggende problemen en een verwijswens bij patiënt-
en met kanker
In hoofdstuk 2 zijn de optimale DT-afkapwaardes voor patiënten met verschillende 
soorten kanker onderzocht. Op basis van de afkapscore kunnen patiënten opgespoord 
worden met klinisch verhoogde distress (case). Het doel van de studie was het onder-
zoeken van de hypothese dat distress en de afkapwaarde afhankelijk zijn van het soort 
kanker en/of van het type behandeling. De effecten van sociaal-demografische en an-
dere ziekte-gerelateerde variabelen op distress werden ook onderzocht. Een grote het-
erogene groep van patiënten met kanker werd geïncludeerd (N=1340), variërend in 
sociaal-demografische en ziekte-gerelateerde kenmerken. De resultaten wezen uit dat 
patiënten met prostaatkanker minder distress rapporteren dan patiënten met borst-, 
spijsverterings-, long-, gynaecologische, hoofd/hals- en lever/hersenen/schildklier-
kanker. Ook werd een lagere afkapwaarde van ≥4 op de DT gevonden bij patiënten 
met prostaatkanker in vergelijking met de afkapwaarde van ≥5 voor borst-, spijsver-
terings-, gynaecologische en hoofd/hals-kankerpatiënten. Lagere distress bij patiënten 
met prostaatkanker leek deels gerelateerd aan de behandeling. Twee-derde van de 
prostaatkankerpatiënten hadden (nog) geen behandeling ontvangen maar bij hen werd 
het verloop van de ziekte afgewacht (ook wel “watchful waiting” genoemd) of patiënt-
en ondergingen alleen een operatie of radiotherapie. Deze niet-intensief behandelde 
prostaatkankerpatiënten rapporteerden minder distress dan intensief behandelde 
prostaatkankerpatiënten (een behandeling die meer behelsde dan alleen een operatie 
of radiotherapie of “watchful waiting”) en dan intensief behandelde niet-prostaatkank-
erpatiënten (een behandeling die meer inhield dan alleen een operatie). Opvallend 
is dat niet-intensief behandelde prostaatkankerpatiënten ook minder distress rap-
porteerden dan niet-intensief behandelde niet-prostaatkankerpatiënten. Naast het 
hebben van een soort van kanker anders dan prostaatkanker, was een hogere distress 
score gerelateerd aan een behandeling die meer inhield dan alleen een operatie en 
jongere vrouwen bleken meer risico te lopen op hogere distress dan oudere vrouwen 
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en dan mannen. De DT-afkapwaardes die in het huidige onderzoek zijn bepaald (≥4 of 
≥5, afhankelijk van het soort van kanker en de intensiteit van de behandeling) kunnen 
worden gebruikt als een eerste screening op de aanwezigheid van klinisch verhoogde 
distress. Aangezien de sensitiviteit en specificiteit van de DT niet 100% zijn, kunnen de 
geïdentificeerde risicofactoren (een soort van kanker anders dan prostaatkanker, een 
intensievere behandeling dan alleen een operatie en het zijn van een jongere vrouw) 
verder helpen bij de identificatie van patiënten die het risico lopen op klinisch ver-
hoogde distress. Deze informatie kan als leidraad dienen in de klinische besluitvorming 
welke patiënten te verwijzen naar psychosociale en/of paramedische zorg.
Het uiteindelijke doel van distress screening is om patiënten door te verwijzen 
naar passende psychosociale en/of paramedische zorg, indien nodig of gewenst, voor 
de behandeling van geïdentificeerde problemen. Er is echter geen sluitend bewijs 
voorhanden met betrekking tot de factoren die gerelateerd zijn aan het hebben van 
een verwijswens. Daarom is in hoofdstuk 3 gekeken naar de effecten van distress en 
problemen, sociaal-demografische en ziekte-gerelateerde variabelen en de sociale ste-
un die patiënten ervaren op de verwijswens. Dezelfde grote heterogene groep patiënt-
en als in hoofdstuk 2 is daarvoor gebruikt. Dertien procent van de patiënten wenste 
een verwijzing naar psychosociale en/of paramedische zorg, terwijl 21% een verwijzing 
overwoog. Voor vijf variabelen werd een onafhankelijk effect gevonden op het heb-
ben van een verwijswens: patiënten die meer distress rapporteerden en/of meer prob-
lemen in het praktische of emotionele domein, die ten tijde van het onderzoek een 
medische behandeling ondergingen (gerelateerd aan kanker) of recent waren gediag-
nosticeerd, en patiënten die jonger waren, hadden vaker een wens om doorverwezen 
te worden. De mate van distress en de aanwezigheid van emotionele en praktische 
problemen leken betere voorspellers van een verwijswens dan sociaal-demografisch 
en ziekte-gerelateerde kenmerken en sociale steun. Dit is nog niet eerder aangetoond 
en suggereert dat de antwoorden op de Lastmeter bruikbaardere informatie verstrek-
ken aan zorgverleners bij het nemen van beslissingen over wie te verwijzen dan alleen 
sociaal-demografische en ziekte-gerelateerde kenmerken en sociale steun. Patiënten 
met klinisch verhoogde distress (DT≥5) hadden een drie keer zo grote kans om een 
verwijswens te rapporteren dan patiënten met een score onder het afkappunt (DT<5). 
Echter, niet alle patiënten met klinisch verhoogde distress uitten een verwijswens en 
sommige patiënten met lage distress wensten een verwijzing. Dit kwam ook naar vor-
en uit de bevinding dat variabelen die samenhangen met een hogere distress score 
(hoofdstuk 2) niet identiek zijn aan de variabelen die samenhangen met een verwi-
jswens (hoofdstuk 3). Patiënten met prostaatkanker rapporteerden bijvoorbeeld mind-
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er distress dan patiënten met andere soorten kanker, terwijl het percentage patiënten 
met prostaatkanker dat een verwijzing wenste vergelijkbaar was met dat van patiënten 
met een niet-prostaat soort van kanker. Deze resultaten suggereren dat screening van 
distress behulpzaam is bij het identificeren van patiënten met een hoge symptoomlast, 
maar onvoldoende is om te bepalen wie extra zorg zou willen of nodig heeft, zelfs 
wanneer het wordt gebruikt in combinatie met de risicovariabelen die in hoofdstuk 
3 werden geïdentificeerd. Dit onderstreept het belang van het bespreken van de ant-
woorden op de Lastmeter inclusief de mate van distress, problemen en de verwijswens 
met alle patiënten, ongeacht of hun distress score boven of onder het afkappunt ligt. 
Dit proces is van cruciaal belang om adequaat te kunnen beslissen welke patiënten een 
verwijzing nodig hebben en naar welk type zorgverlener.
In hoofdstuk 4 zijn distress, onderliggende problemen, verwijswens en gebruik van 
psychosociale en paramedische zorg onderzocht in een cross-sectionele groep van 
overlevenden van borstkanker. De variabelen zijn gemeten op twee tijdstippen met 
een tijdsinterval van één jaar. De overlevenden hadden tussen één tot vijf jaar geleden 
een behandeling met chemotherapie afgerond. Ook is onderzocht welke sociaal-de-
mografische en ziekte-gerelateerde variabelen en welke problemen gerelateerd 
zijn aan aanhoudende verhoogde distress. Aanhoudende verhoogde distress werd 
gedefinieerd als een distress (DT) score van 5 of hoger gemeten op beide tijdstippen. 
Tenminste 1/3 van de overlevenden ervoer klinisch verhoogde distress op één van de 
tijdstippen (DT≥5), en één op de vier overlevenden rapporteerde klinisch verhoogde 
distress op beide tijdstippen. Een kortere tijd sinds diagnose, een hogere mate van 
zorggebruik, en meer praktische, sociale, emotionele en/of lichamelijke problemen 
vergrootte de kans dat overlevenden aanhoudende verhoogde distress rapporteerden. 
Lichamelijke problemen waren het sterkst gerelateerd aan aanhoudende verhoogde 
distress. Vermoeidheid en gebrek aan conditie werden het vaakst als probleem gen-
oemd door overlevenden. Een groot deel van de overlevenden heeft of had onders-
teunende gezondheidszorg ontvangen, meestal van een psycholoog en/of een fysio-/
lymfoedeemtherapeut. Elf procent van de overlevenden wenste een verwijzing en 37% 
overwoog een verwijzing. Bij de beoordeling één jaar later, wenste 16% een verwijzing 
en overwoog 17% een verwijzing. Deze resultaten wijzen erop dat het opsporen en 
behandelen van distress belangrijk zijn, ook jaren nadat de behandeling met chemo-
therapie is afgerond. Aandacht van zorgverleners voor lichamelijke problemen, vooral 
voor vermoeidheid en gebrek aan conditie, is extra belangrijk omdat deze problemen 
het sterkst samenhangen met aanhoudende verhoogde distress.
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Deel 2 | Online programma’s voor patiënten met kanker
Veel patiënten met kanker wenden zich tot het internet om te zoeken naar informatie 
over hun ziekte. Reeds in 2007 toonde een Nederlands cross-sectioneel onderzoek 
over kanker-gerelateerd internetgebruik aan dat 60% van de patiënten vaak het inter-
net doorzocht en 9% van de patiënten vroeg anderen om naar informatie te zoeken. 
Online (zelf)hulpprogramma’s lijken bijzonder geschikt om ondersteunende zorg te ver-
lenen en kunnen patiënten bovendien helpen bij zelfmanagement van psychosociale 
en lichamelijke symptomen. Over het algemeen hebben patiënten met kanker een pos-
itieve houding ten opzichte van zelfmanagement aan de hand van online (zelf)hulp. 
In het tweede deel van dit proefschrift onderzochten we de effecten van online 
(zelf)hulpprogramma’s op patiënt-gerapporteerde uitkomsten. Om de bestaande ken-
nis over de effecten van online (zelf)hulpprogramma’s te vergroten, werd systematisch 
literatuuronderzoek uitgevoerd in hoofdstuk 5. Aan de hand van deze literatuuranalyse 
werd nagegaan of deze programma’s psychosociale en/of lichamelijke symptomen, als 
gevolg van de diagnose en de behandeling van kanker, kunnen verlichten. Zoekop-
drachten in databases en referentielijsten resulteerden in de selectie van 16 studies 
die voldeden aan onze criteria. De resultaten toonden aan dat de meerderheid van 
de geïncludeerde studies (9 van 16 studies) positieve effecten rapporteerden, vooral 
op uitkomsten als vermoeidheid, ervaren sociale steun en angst. De literatuuranalyse 
deed ook een eerste poging om de effectiviteit van de online (zelf)hulpprogramma’s 
te koppelen aan de inhoud van de programma’s. De effectiviteit varieerde tussen de 
verschillende typen programma’s. Alle studies waarin programma’s werden onder-
zocht die meerdere functionaliteiten bevatten zoals informatie/psycho-educatie, mo-
gelijkheden voor communicatie met een zorgverlener en/of coaching services, rap-
porteerden minstens één significant positief effect, voornamelijk op sociale steun en 
kwaliteit van leven. Echter, slechts één van de geïncludeerde studies waarin patiënten 
op internetfora onderling contact hadden over psychosociale en/of lichamelijke symp-
tomen die zij ervaarden, liet een positief effect zien. Dit was ook het geval voor studies 
waarin face-to-face therapie voor specifieke symptomen (bijvoorbeeld seksuele prob-
lemen, depressieve symptomen) werd vervangen door online communicatie. 
De methodologische kwaliteitsbeoordeling toonde aan dat veel studies over online 
(zelf)hulpprogramma’s verbetering behoeven met betrekking tot de studie opzet en/of 
de wijze van rapporteren over het onderzoek. Ook maakten de geïncludeerde studies 
gebruik van veel verschillende uitkomstmaten. Door deze methodologische zwakheden 
en heterogeniteit in uitkomstmaten is het lastig om heldere conclusies te kunnen trek-
ken over de effectiviteit van online (zelf)hulpprogramma’s. Meer onderzoek is nodig 
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waarbij kwalitatief hoogstaande studiemethoden en rapportagestandaarden worden 
gebruikt (zoals de ‘Consolidated Standards of Reporting Trials (CONSORT)-statement 
for eHealth’) voordat een definitieve(re) conclusie kan worden getrokken.
Hoofdstuk 6 beschrijft een gerandomiseerde studie waarin werd onderzocht wat 
de effecten zijn van het online ‘ENCOURAGE-programma’. Patiënten met borstkank-
er afkomstig uit twee verschillende ziekenhuizen werden at random in de interven-
tiegroep geplaatst (ENCOURAGE-programma) of in de controlegroep. Het ENCOUR-
AGE-programma is een online programma waarin psycho-educatie op maat wordt 
gegeven aan patiënten met borstkanker die hun primaire behandeling minder dan 
een jaar geleden hebben afgerond. Het doel van het programma is om patiënten te 
helpen in het omgaan met eventuele psychosociale en/of lichamelijke gevolgen van de 
diagnose en behandeling(en) en uiteindelijk om hun leven weer op te kunnen pakken. 
Verschillende patiënt-gerapporteerde uitkomsten werden gebruikt om het effect van 
het programma te testen, inclusief de primaire uitkomstmaat ‘optimisme en gevoe-
lens van controle over de toekomst’. Van de patiënten was 71% het (volledig) eens 
met de stelling dat hij/zij positief tegenover het programma stond. In tegenstelling tot 
onze verwachtingen werden geen effecten ten gunste van het ENCOURAGE-program-
ma gevonden wanneer de interventiegroep werd vergeleken met de controlegroep. In 
de controlegroep ontvingen patiënten standaardzorg. In zowel de interventie- als de 
controlegroep ontvingen patiënten een informatiebrochure over borstkanker en een 
brochure over psychosociale aspecten van kanker. Nadere subgroep analyses wezen 
uit dat het ENCOURAGE-programma wel een positief effect had op de primaire uitkom-
stmaat voor patiënten met klinisch verhoogde distress (DT score ≥5) in de interven-
tiegroep in vergelijking met patiënten met verhoogde distress in de controlegroep. De 
effectgrootte was gemiddeld tot groot (Cohen’s d = 0.65), hetgeen een relevant verschil 
aangeeft. Ook gaf 81% van de patiënten met verhoogde distress aan dat zij het (volle-
dig) eens waren met de stelling dat hij/zij positief tegenover het programma stond. Het 
programma is dus mogelijk effectief voor patiënten met klinisch verhoogde distress. 
Deze hypothese moet echter nog verder worden getest omdat het aantal patiënten 
waarover de analyses zijn gedaan klein was. 
De afwezigheid van positieve resultaten voor de totale groep kan mogelijk ook 
worden verklaard door het ontwerp van het programma en/of door het tijdstip wa-
arop patiënten startten met het gebruik ervan. Het ENCOURAGE-programma maakt 
gebruik van een probleemoplossende oriëntatie. Echter, in het programma werd niet 
gebruik gemaakt van alle vijf fases van de probleemoplossende therapie (PST): hoewel 
probleemoriëntatie en probleemdefinitie aan bod kwamen werden de andere fases 
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(bedenken van oplossingen, kiezen van een oplossing en implementatie en evaluatie 
van de oplossing) alleen impliciet behandeld in het psycho-educatieve materiaal. Ti-
jdens de 12 weken dat patiënten toegang hadden tot het programma werden zij dus 
niet door alle PST fasen geleid, wat mogelijk heeft bijgedragen aan de afwezigheid van 
effecten. Het is dan ook aan te raden om alle PST fasen in het ENCOURAGE-programma 
te incorporeren inclusief huiswerkopdrachten om nieuw verworven vaardigheden te 
oefenen. Het aangepaste programma kan het beste getest worden bij patiënten met 
klinisch verhoogde distress, onmiddellijk na voltooiing van chemotherapie om ervoor 
te zorgen dat patiënten in een vroege fase ondersteuning krijgen. Concluderend, de 
resultaten van de ENCOURAGE-studie zijn veelbelovend, omdat patiënten die veel dis-
tress rapporteerden ENCOURAGE positief beoordeelden en lijken te profiteren van de 
interventie. De bovengenoemde kwesties kunnen als startpunt worden gebruikt voor 
verdere verbetering en gebruik van het programma. 
CONCLUSIE
Aandacht voor de mate van distress en van de aard van onderliggende problemen is 
van groot belang voor patiënten met kanker om het leven weer op te kunnen pakken 
na de diagnose en de behandeling(en). Psychosociale signalering vormt een belangrijk 
element in het ondersteunen van patiënten. Kennis van factoren die samenhangen met 
veel distress, problemen en het hebben van een verwijswens (welke in dit proefschrift 
zijn geïdentificeerd), kan helpen bij een optimaal gebruik van de Lastmeter door zorg-
verleners en daarmee in het adequaat verwijzen van patiënten die behoefte hebben 
aan extra professionele hulp voor hun problemen. Dit proefschrift toonde ook aan dat 
online (zelf)hulpprogramma’s haalbaar en effectief kunnen zijn in het verlichten van 
problemen van patiënten. Het is de verwachting dat het bewijs voor de effectiviteit 
van online (zelf)hulpprogramma’s de komende jaren verder zal toenemen. Zowel het 
proces van psychosociale signalering als het gebruik van online (zelf)hulpprogramma’s 
kunnen een waardevolle aanvulling zijn op de traditionele zorg voor patiënten met 
kanker. Hopelijk zullen deze methoden binnenkort wereldwijd volledig onderdeel zijn 
van de dagelijkse zorg voor patiënten met kanker.
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Dutch and English versions of the DT/PL
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Eindelijk is het zover: mijn proefschrift is af! Hoewel ik het traject niet altijd gemakkelijk 
vond, had ik deze ‘PhD journey’ niet willen missen. Vele leerzame en leuke ervaringen 
neem ik met me mee. Ervaringen die ik (ook) aan jullie te danken heb. Graag wil ik ieder-
een die aan mijn proefschrift heeft bijgedragen hierbij bedanken. Een aantal personen wil 
ik graag in het bijzonder noemen.
Mijn onderzoek zou onmogelijk zijn geweest zonder de deelname van de patiënten. De 
patiënten hebben de tijd en moeite genomen om vragenlijsten in te vullen, gesprekken 
te voeren, en om mailtjes en telefoontjes te beantwoorden. Individuele reacties zijn niet 
terug te vinden in dit proefschrift, maar zijn van grote waarde geweest voor het begrijpen 
van de resultaten: veel dank!
Veel dank gaat uit naar mijn promotoren en co-promotor: prof. dr. A.K.L Reyners, dr. C.P. 
Schröder en dr. J.E.H.M. Hoekstra.
Beste An, als niet-arts was het voor mij best even wennen om mijn weg te vinden binnen 
de Medische Oncologie. Vanaf het begin af aan heb je mij onder je hoede genomen: 
ik vond het erg fijn om te weten dat je deur altijd openstond voor mijn vragen. Ik heb 
bewondering voor jouw kennis en kunde van zowel de patiëntenzorg als de wetenschap 
en hoe je met een scherpe blik en daadkracht je werk doet. Je hebt me erg geholpen het 
overzicht over mijn proefschrift te houden en kwam met creatieve ideeën wanneer ik 
vastliep. Heel erg bedankt voor jouw geduld en steun en dat jij mij altijd stimuleerde om 
het beste uit mijzelf te halen.
Beste Carolien, als expert op het gebied van borstkanker, heb jij mij wegwijs gemaakt in 
de ‘wereld van borstkanker’. Die wereld was nieuw voor mij: ik ben je erg dankbaar dat ik 
hierin veel van je heb mogen leren. Ik heb er bewondering voor hoe jij teksten kan her-
schrijven zodat ze mooier en aansprekender worden. Dat heeft mij meermaals geholpen. 
Je nuchterheid en humor staan mij het meeste bij van onze supervisiegesprekken en kon 
ik altijd erg waarderen.
Beste Josette, toen ik een aantal maanden op weg was, leerde ik jou kennen. Je had 
nog wel wat ‘data op de plank liggen’ en je zocht iemand die hier artikelen over wilde 
schrijven. Wat een prachtige kans. Samenwerken met jou was altijd een feest. Jouw en-
thousiasme en inspanningen tijdens het schrijfproces hebben mij heel erg geholpen. Ik 
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bewonder jouw enorme kennis van de psycho-oncologie en hoe jij manuscripten naar 
een hoger niveau kon tillen. Ook hield je oog voor mij als persoon en maakte je altijd 
ruimte voor een privégesprek. Je bent een grote inspiratiebron en steun voor mij geweest 
gedurende dit gehele traject, ontzettend bedankt.
De leden van de leescommissie, prof. dr. H.B.M. van de Wiel, prof. dr.  J.A. Gietema en 
prof. dr.  J.E.A. Portielje, wil ik hartelijk bedanken voor hun tijd en bereidheid om mijn 
proefschrift te beoordelen.
Alle co-auteurs wil ik graag hartelijk bedanken voor hun bijdrage aan de uitvoeren van het 
onderzoek en/of het schrijven van de artikelen.
Prof. dr. E.G.E. de Vries, beste Liesbeth, toen ik begon aan mijn promotietraject was jij 
hoofd van de afdeling. Ik ben je zeer erkentelijk dat je mij de kans hebt gegeven om aan 
dit traject te starten. Je kennis en kunde, zowel op klinisch als wetenschappelijk vlak, zijn 
indrukwekkend. Bedankt dat ik daarvan heb mogen leren.
Beste Grytsje Bouma, het schrijven van een review artikel was voor ons beiden een nieu-
we ervaring. Het was altijd prettig om met je samen te werken. Dank voor jouw gezellig-
heid, harde werken en geduld tijdens dit proces.
Beste Annette van der Velden, ik ben je erg dankbaar dat ik voor de ENCOURAGE studie 
ook bij de Medische Oncologie van het Martini Ziekenhuis patiënten kon werven. Als ik 
vragen had, kon ik altijd bij je aankloppen. Leuk dat we nu, in het kader van de palliatieve 
zorg, weer samenwerken.
Beste Hans Burgerhof, dank voor jouw statistische ondersteuning bij twee artikelen in dit 
proefschrift. Je nam altijd rustig de tijd voor mijn vragen. Het was erg fijn om met iemand 
te kunnen sparren wanneer ik statistisch ‘vastzat’.
Beste Wemke Tuinier, dankzij jou kon ik vrijwel meteen met de dataverzameling starten: 
in het kader van je opleiding was jij begonnen aan een studie bij patiënten met borstkank-
er. Hiervan heb ik veel geleerd, niet in de laatste plaats omdat ik voor jouw studie veel 
patiënten heb gesproken. Bedankt voor de fijne samenwerking.
Dr. Walenkamp, beste Annemiek, als niet-arts ben ik door jou toch heel wat te weten 
gekomen over neuro-endocrine tumoren. Dank voor jouw heldere input bij het schrijven 
van de artikelen.
Prof. dr. G.A.P. Hospers, beste Geke, we mochten samen één artikel schrijven voor dit 
proefschrift. Jouw enthousiaste reacties via de e-mail blijven me bij.
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Graag bedank ik alle medewerkers van het IKNL, locatie Groningen. Ik was altijd van harte 
welkom bij jullie om de data uit te pluizen en om aan mijn artikelen te werken. Veel dank 
voor jullie gezelligheid en hulp wanneer ik vragen had. 
Beste Ineke Schutte-Hoogstraten, als ‘patient advocate’ was jij betrokken bij het schrijven 
van de teksten voor de ENCOURAGE website. Ik ben je dankbaar voor jouw waardevolle 
input.
Mijn oprechte dank gaat uit naar de researchverpleegkundigen van de Medische Oncolo-
gie van het Martini Ziekenhuis: Gery Dijkinga, Esmeralda Bolt en Joke Engel. Bedankt voor 
jullie inspanningen in het werven van patiënten.
De inzet van ‘onze’ oncologieverpleegkundigen waardeer ik ook zeer. Henny en Margreet, 
bedankt voor het benaderen van patiënten voor de verschillende studies tijdens mijn af-
wezigheid door vakanties/zwangerschapsverlof. Ik vond het ook heel fijn dat ik jullie altijd 
kon bevragen over de details van de verschillende medische behandelingen.
De gehele staf van de Medische Oncologie wil ik graag bedanken voor de medewerking 
in het werven van patiënten voor de studies.
Gerry, mijn allereerste weken bij jou op de kamer zal ik niet snel vergeten. Bedankt 
dat je me wegwijs hebt gemaakt en voor je gezelligheid. Hoewel onze klimatologische 
voorkeuren niet helemaal overeen kwamen, hebben we het toch heel gezellig gehad.
Van grote hulp was het secretariaat van de Medische Oncologie: Gretha en Hilda. Ik heb 
er bewondering voor dat jullie werk gedaan krijgen tussen alle telefoontjes en mon-
delinge vragen door. Bedankt dat ik met mijn vragen altijd bij jullie terecht kan.
Andere (oud-)collega’s binnen het UMCG, Marijke en Floor, bedankt voor jullie gezel-
ligheid en inspiratie.
Mijn huidige kamergenoten wil ik graag bedanken voor jullie steun bij de laatste loodjes 
van mijn proefschrift.
Anouk, je bent altijd bereidheid om te helpen of om advies te geven. Ik waardeer het zeer 
dat je me hebt geholpen met de Nederlandse samenvatting van dit proefschrift.
Bianca, dank voor jouw secretariële ondersteuning tijdens de eerste jaren van mijn pro-
motie-traject en voor de gezelligheid en goede adviezen die ik nu van je ontvang.
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Kim, bedankt voor jouw gezelligheid en steun. Wie weet (hopelijk) begin jij ook nog eens 
aan een promotietraject als diëtist-onderzoeker.
Irene en Jenske, jullie lopen (bijna) vanaf het begin met me mee: wat ben ik blij dat jullie 
mijn paranimfen zijn. 
Irene, ruim een jaar na de start van mijn promotie kwam jij me vergezellen. Als mede 
‘niet-arts wel-onderzoeker’ was het heel fijn om dingen met jou te kunnen bespreken. Ik 
denk met veel plezier terug aan onze kopjes koffie en blokjes om terwijl we lief-en-leed 
deelden. Fijn dat we, ondanks de vele verhuizingen, altijd kamergenoten zijn gebleven. 
Ontzettend bedankt voor jouw gezelligheid en liefdevolle support!
Jenske, een opgewekte en gedreven zorgprofessional: dat zijn woorden die mij bij jou te 
binnen schieten. Ik vond het altijd inspirerend en prettig om met je samen te werken. 
Dankzij jou kon de dataverzameling tijdens mijn zwangerschapsverlof gewoon door-
lopen, dank! Aan onze spinninglessen zal ik altijd met veel plezier terugdenken.
Lieve familie en vrienden, jullie niet aflatende interesse in mijn proefschrift en bemoedig-
ing hielpen me om gemotiveerd te blijven, veel dank!
Dat een proefschrift schrijven teamwork is, kan mijn (schoon)familie van getuigen.
Graag bedank ik mijn lieve schoonzussen, Roeletta, Agnes, Myrna en Evelien voor jullie in-
teresse en praktische steun, bijvoorbeeld in de vorm van oppassen. Roeletta, mijn bijzon-
dere dank gaat naar jou uit. Ik kon de kinderen altijd brengen wanneer ik dat vroeg. We 
hebben genoten van het ‘weekendje’ weg ter ere van het afronden van dit proefschrift!
Lieve schoonpa en ma, veel dank voor jullie liefdevolle steun en het vele oppassen. 
Zonder alle maandagen dat ik bij jullie aan het schrijven kon, was het erg moeilijk ge-
worden om mijn proefschrift af te ronden.
Lieve pap en mam, zonder jullie onvoorwaardelijke liefde en steun was ik überhaupt niet 
bij een promotietraject uitgekomen. Ook zonder het vele oppassen van jullie weet ik niet 
hoe ik het tot een goed einde had moeten brengen. Ontzettend bedankt dat jullie altijd 
voor mij klaar staan en in mij geloven. 
Lieve Hester, ik had me geen lievere zus kunnen wensen dan jij. Heel erg bedankt dat je 
altijd met me mee leeft en wilt helpen waar mogelijk. Als iemand een doorzetter is dan 
ben jij het wel. Supertrots op jou!
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Dankwoord
Lieve Duurt, het promotietraject heeft niet alleen van mij veel gevraagd maar ook van 
jou. Maar het is gelukt! Ontzettend bedankt voor jouw betrokkenheid, steun, geduld en 
liefde. 
Lieve Hein, Stef & Esther, mama houdt van jullie, tot aan de maan…en terug.
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